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Abstract 
 Spt7 is a 1,332 residue protein critical for maintaining structural integrity of the 
SAGA complex. I demonstrated that the extreme N-terminus of Spt7 plays an important 
role in SAGA function. Deletion of the first 73 (Spt773-1332) and 121 (Spt7121-1332) N-
terminal residues resulted in slow growth, decreased transcriptional activation at PHO5 and 
INO1, and a partial decrease in acetylation at lysine 18 of histone H3 at PHO5. The 
Spt7121-1332 mutant did not affect Spt7’s association with Gcn5 or Tra1, or its localization 
within the cell. Mutation of the first four positively charged residues to glutamine severely 
reduced PtdInsP binding by Spt7. I mapped this binding to the first two positively charged 
residues, arginine 4 (R4) and lysine 8 (K8). Overall, the N-terminus of Spt7 is important for 
the function of SAGA, likely in part through its ability to bind PtdInsPs. 
!
!
!
!
!
!
!
!
!
!!
Key words: Transcriptional regulation, SAGA complex, Spt7, Gcn5, acetylation, 
Phosphatidylinositol phosphate, Tra1, Tti2 
!ii
Co-authorship Statement 
 Work from Genereaux et al (2012) is included in this thesis. I performed all of the 
fluorescence microscopy shown in Figure 3.12, 3.13, and 3.14, with the assistance of Dr. 
Karagiannis, who kindly allowed me to use his microscope. In addition, I analyzed the 
visual data and calculated the ratio of nuclear to cytoplasmic eGFP signal for Tra1-F3744A 
in the context of wild-type Tti2 or the Tti2-F328S suppressor, as illustrated in Table 3.1. 
Generation and preparation of the Saccharomyces cerevisiae strains used for microscopic 
analysis was done by Dr. Brandl. The growth assay shown in Figure 1.5 was also done by 
Dr. Brandl.  
!iii
Acknowledgements 
First and foremost, I would like to thank my supervisor, Dr. Brandl, for his constant 
guidance and support during my time as a graduate student. His insight and deep level of 
knowledge have always been nothing short of inspiring, and I am very grateful for all of the 
time he has dedicated to helping me grow as a scientist. On a more specific note, I would 
like to thank him for performing all of the tetrad dissections mentioned in this thesis. 
It was of course a pleasure to share and discuss my work with my co-supervisors, 
Dr. Ball and Dr. Litchfield, as they always provided me with great feedback and 
encouragement; thank you both! Another professor who helped me tremendously in my 
work was Dr. Karagiannis, who taught me the subtle ways of fluorescence microscopy, and 
allowed me to use his microscope to achieve the visual results presented in this thesis. 
Next, I would like to thank Julie Genereaux for all of her amazing support in the lab. 
Without her I would undoubtedly be very lost at times. In addition, I would also like to 
extend a big thank you to Steven Hoke, Stephanie Kvas, Lance DaSilva, Tom Kolaczyk, 
Simon Lam, Samantha Pillon and Aaron Simkovich, as well as all other past and present 
members of the Biochemistry Department for making my two years a great experience: you 
know who you are! 
Lastly, I would like to thank my parents Tomas and Simona, for their unwavering 
support and belief in me. Likewise, my siblings have always played a positive and 
inspirational role in my life. Overall, I greatly appreciate the Department of Biochemistry at 
Western for giving me the opportunity and facilities to contribute to the field of science; I 
hope I have pushed it forward ever so slightly. 
!iv
Table of Contents
Certificate of Examination i
Abstract ii
Co-authorship statement iii
Acknowledgements iv
Table of Contents v
List of Tables viii
List of Figures ix
List of Abbreviations x
Chapter 1: Introduction
1.1 Transcriptional Regulation    2
1.2 SAGA complex 6
1.3 Spt7 11
1.4 Phosphatidylinositol Phosphates 16
1.5 Tra1 18
1.6 Tti2 22
1.7 Thesis Overview 24
Chapter 2: Materials and Methods
2.1 Yeast strains 27
2.2 DNA constructs 29
2.3 Growth assays 32
2.4 β-galactosidase assay 32
2.5 Chromatin Immunoprecipitation 33
2.6 Western blotting 34
2.7 Immunoprecipitation 34
2.8 Gel filtration chromatography 35
                                                                         v
2.9 Fluorescence microscopy 35
2.10 Lipid overlay assays 36
Chapter 3: Results
3.1 Lack of the N-terminal 121 residues of Spt7 results in decreased protein 
expression
37
3.2 N-terminal truncations of Spt7 decrease growth under various conditions 39
3.3 N-terminal truncations of Spt7 reduce transcriptional activation at SAGA-
targeted promoters
41
3.4 N-terminal truncations of Spt7 partially decreases acetylation of H3K18 at 
PHO5 in vivo
43
3.5 Effect of the N-terminal Spt7121-1332 truncation mutant on interaction with Tra1 45
3.6 Investigating the effect of Spt7121-1332 on Spt7-Gcn5 interaction via gel filtration 
analysis
47
3.7 Localization of Spt773-1332 and Spt7121-1332 via fluorescence microscopy 49
3.8 Lipid binding by the extreme N-terminus of Spt7 52
3.9 Changes in lipid binding specificity by Spt7 N-terminal mutant fragments 54
3.10 Phenotypes of strains carrying N-terminal point mutations 56
3.11 Spt7 localization in the context of fab1 and vps34 deletion backgrounds 58
3.12 Localization of Tti2 and Tti2-F328S 58
3.13 Localization of Tra1, and Tra1-F3744A in presence and absence of Tti2-F328S 60
3.14 Comparing localization of Tra1-F3744A with membrane constituents 65
Chapter 4: Discussion
4.1 The N-terminal 121 residues of Spt7 are necessary for its full expression 69
4.2 The lack of the first 73 and 121 amino terminal residues severely affects growth 
and transcriptional activation at SAGA targeted promoters
69
4.3 The extreme N-terminal region of Spt7 is necessary for acetylation at lysine 18 
of histone H3 at the PHO5 promoter
72
                                                                        vi
4.4 The N-terminal truncation of Spt7 has no effect on its interaction with Tra1 and 
Gcn5
73
4.5 Spt7 localization is unaltered in the context of N-terminal truncations 75
4.6 Lipid binding by Spt7 is important for its function 76
4.7 eGFP-tagged Spt7 mislocalizes in fab1 and vps34 deletion strains 79
4.8 Suppression of Tra1-F3744A by Tti2-F328S is partially achieved via an affect on 
its localization
80
4.9 Model and Conclusions 81
References 85
Appendix 95
List of strains, DNA constructs and Oligonucleotides used in this study
Curriculum Vitae 101
                                                                        vii
List of Tables
Table 1.1: List of all identified SAGA components 7
Table 3.1: Relative concentrations (fluorescence intensity per unit area) of eGFP-
Tra1 (wild type or F3744A) in the nucleus vs. total cell
64
Table S1: Saccharomyces cerevisiae strains used in this study 95
Table S2: DNA constructs used in this study 97
Table S3: Oligonucleotides used in this study 99
                                                                       viii
List of Figures
Figure 1.1: Schematic of factors involved in RNA Polymerase II transcription 4
Figure 1.2: Schematic representation of the SAGA complex 8
Figure 1.3: Schematic diagram of Saccharomyces cerevisiae Spt7 13
Figure 1.4: Molecular structure of Tra1/TRRAP 20
Figure 1.5: Suppression of Tra1-F3744A by Tti2-F328S (SUP3) 23
Figure 3.1: Comparing expression levels of Spt7WT and Spt7121-1332 38
Figure 3.2: Phenotypes of N-terminal truncations of Spt7  40
Figure 3.3: Effect of N-terminal Spt7 truncations on transcriptional activation at 
PHO5, INO1, an SRE-containing promoter, and RPL35A
42
Figure 3.4: Effect of N-terminal truncations of Spt7 on histone H3 acetylation at 
the PHO5 and PGK promoters
44
Figure 3.5: Tra1-Spt7 immunoprecipitation 46
Figure 3.6: Fractionation of Gcn5 from a Superose 6 size exclusion column from 
strains carrying either Spt7WT or Spt7121-1332 
48
Figure 3.7: Localization of full-length Spt7WT, Spt773-1332, and Spt7121-1332 50/51
Figure 3.8: Lipid binding by N-terminal fragments of Spt7 53
Figure 3.9: Lipid binding by N-terminal mutant fragments of Spt7 55
Figure 3.10: Phenotypes of N-terminal point mutations of full-length Spt7 57
Figure 3.11: Localization of full-length Spt7WT, Spt773-1332, and Spt7121-1332 in the 
context of fab1 and vps34 knockout strains
59
Figure 3.12: Localization of Tti2 and Tti2-F328S 61
Figure 3.13: Localization of Tra1 and Tra1-F3744A in the presence of Tti2 or 
Tti2-F328S
63
Figure 3.14: Localization of eGFP-Tra1-F3744A with RFP-tagged membrane 
constituents
66/67
                                                                        ix
List of Abbreviations 
Ada Alteration/Deficiency in Activation
ASTRA Assembly of Tel, Rvb, and Atm-like kinase
CHD Chromatin organization modifier, Helicase, and DNA-binding domains
DAPI 4',6-diamidino-2-phenylindole
DNA Deoxyribonucleic acid
DUB Deubiquitylation
EDTA Ethylenediaminetetraacetic acid
Fab Forms Aploid and Binucleate cells
FAT FRAP, ATM, TRRAP
FATC FRAP, ATM, TRRAP, C-terminus
Gcn General Control Nonderepressible
GFP Green Fluorescence Protein
GTF General Transcription Factor
HAT Histone Acetyltransferase
HEAT Huntintin, Elongation factor 3, A subunit of protein phosphatase 2A and 
Tor1
INO INOsitol requiring
ISW Imitation SWitch subfamily
MDa Megadalton
mRNA Messenger RNA
NuA4 Nucleosomal Acetyltransferase of histone H4
PAGE PolyAcrylamide Gel Electrophoresis
PIC Pre-Initiation Complex
PS Phosphatidylserine
PtdIns Phosphatidylinositol
PtdInsP Phosphatidylinositol Phosphate
RFP Red Fluorescence Protein
!x
RNA Ribonucleic Acid
RNA Pol II RNA Polymerase II
SAGA Spt-Ada-Gcn5-Acetyltransferase
SALSA SAGA Altered, Spt8 Absent
SC Synthetic Complete
SDS Sodium Dodecyl Sulfate
SLIK SAGA-Like
SNF Sucrose NonFermenting
SPT SuPressor of Ty
STAGA Spt3-Taf9-Ada-Gcn5-acetyltransferase
SWI SWItching deficient
TAF TATA-binding protein associated factor
TBP TATA-binding protein
TBS Tris Buffered Saline
TBST Tris Buffered Saline with Tween 20
TFII Transcription Factor II
TRAAP TRansformation/tRanscription domain-Associated Protein
Tti Two Tel2-Interacting protein
TTT Tel2-Tti1-Tti2
Vps Vacuolar Protein Sorting
YPD Yeast Peptone Dextrose
!xi
!1
Chapter 1: Introduction 
 SAGA (Spt-Ada-Gcn5-Acetyltransferase) regulates approximately 10% of yeast 
genes, most of which are involved in stress response. Although the SAGA complex has 
been studied extensively, the exact role of many of its subunits is not known. Spt7 is a 
1,332 amino acid residue protein that acts as a core component of the SAGA complex in 
Saccharomyces cerevisiae. Along with Spt20 and Ada1, Spt7 is required for the structural 
integrity of the complex (Sterner et al. 1999). An Spt7 deletion results in very slow growth, 
severe phenotypes under conditions of stress, as well as transcriptional defects at SAGA-
targeted genes. The human form of Spt7, STAF65γ, is 414 amino acid residues long, and is 
homologous to the 543 C-terminal end of yeast Spt7. For the most part, previous studies 
have focused on elucidating the function of Spt7 via examination of its C-terminal region, 
which contains a histone-fold motif, as well as a site which controls its interaction with 
another SAGA component, Spt8. In addition, the C-terminus contains a cleavage site, 
which produces an alternate version of Spt7, Spt7SLIK, found in the SAGA-Like (SLIK) 
complex. Prior to undertaking this study, the lab of Fred Winston found that deletion of the 
extreme N-terminus of Spt7 (upstream of residue 851) resulted in partial function of the 
protein, similar in phenotype to strains carrying C-terminally truncated Spt7. I found that 
deletion of the N-terminus (up to residue 73) was consistent with this decreased growth 
phenotype demonstrated by Wu and Winston (2002). This led us to suggest a role for the N-
terminus in Spt7 function. In addition, we observed that every fourth residue for the first 28 
N-terminal residues is either a lysine or arginine. Since phosphatidylinositol phosphate 
!2
(PtdInsP) binding motifs often consist of a pattern of positively charges residues, we 
predicted that SAGA may be partly regulated by the binding of PtdInsPs by Spt7. 
 Besides furthering our understanding of Spt7’s functioning in yeast, I was also 
involved in studying the role of Tra1, SAGA’s largest subunit. My main goal was to 
determine the function of the FATC domain via the nature of suppression of the Tra1-
F3744A mutant by an allele of Tti2 harbouring a phenylalanine to serine mutation at 
residue 328 (Tti2-F328S). I contributed to this research by performing fluorescence 
microscopy to track the localization of eGFP-tagged Tra1-F3744A, and whether any 
mislocalization due to the mutation would be rescued by the presence of the suppressor.  
!
1.1 Transcriptional regulation 
 Eukaryotic transcription is a highly regulated process that involves numerous 
protein factors acting in a co-ordinated manner. These factors often function as part of large 
multi-subunit complexes acting in response to a wide variety of environmental signals. In 
general, transcription requires a core promoter as the platform for the assembly of the pre-
initiation complex (PIC) consisting of several general transcription factors (GTFs) along 
with RNA polymerase II (pol II). The GTFs include TFIIA, TFIIB, TFIID, TFIIE, TFIIF, as 
well as TFIIH, and are recruited to the promoter via the TATA-binding protein (TBP) which 
is part of the TFIID  (transcription factor II D) complex. Specifically, TFIIA and TFIIB 
bind TFIID/TBP in a sequential manner after TFIID is docked at target DNA sites 
(containing TATA consensus sequences) during formation of the PIC (Buratowski et al. 
1989). TBP is also found individually within the nucleus, and can be bound directly by the 
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SAGA complex to facilitate its successful recruitment to the promoter and thus facilitate 
transcription of SAGA-targeted genes (Sterner et al. 1999). The assembly of the PIC alone 
on the core promoter is sufficient for basal transcription (reviewed by Kronberg 2001; Hahn 
and Young, 2011). However, gene specific regulation requires activators or repressors 
which bind to specific sites on DNA to facilitate or prevent transcription, respectively. 
Furthermore, there are a number of transcriptional co-regulators that bind to, and regulate 
the mechanism of action of various transcription factors on target DNA (Figure 1.1) 
(reviewed by Thomas and Chiang, 2006). 
 Except for sites encoding some housekeeping genes, most DNA in the cell is tightly 
wound around two molecules of each of the conserved histone proteins (H2A, H2B, H3, 
and H4). The structures formed by DNA and histone proteins, nucleosomes, are further 
compacted into a highly condensed chromatin structure during periods of transcriptional 
inactivity. This highly compacted DNA must be unwound and spatially accessible for the 
binding of GTFs, activators, coactivator complexes and RNA polymerase II in order for 
transcription to commence. This is achieved by the combined action of chromatin 
remodelers, which utilize ATP to physically slide (Fazzio and Tsukiyama, 2003), or 
displace (Boeger et al. 2004) histone octamers from target DNA. Four different families are 
found in yeast, including Swi/Snf, Isw, Chd, and Ino80; their mechanisms of action differ 
such that the Swi/Snf class of remodelers affect nucleosome stability, and the Isw class 
facilitates nucleosome sliding (reviewed by Rando and Winston, 2012). 
 Chromatin modifying complexes also play a key role in regulating transcriptional 
dynamics. There are at least eight known types of chromatin modifications: acetylation, 
!4
Figure 1.1: The intricate interplay of activators, chromatin remodelers, general 
transcription factors, and coactivator complexes drives RNA polymerase II transcription. 
Gap in DNA represents any number of base pairs (Figure adapted from Kvas, 2012). 
Illustration of nucleosomes courtesy of Elsevier Inc. Kelley’s Textbook of Rheumatology) 
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methylation, ubiquitylation, phosphorylation, sumoylation, ADP ribosylation, deimination 
and proline isomerization. Acetylation, the most common form of modification, is driven 
by acetyltransferases that add acetyl groups to lysine residues on histone tails. These N-
terminal tails constitute approximately 30% of the mass of histones; however they are not 
visible when subjected to crystallography due to their highly unstructured nature. The 
positive charges on the lysine residues are thought to neutralize electrostatic interactions 
between the negative phosphate backbone of the DNA and the positively charged histone 
proteins. Thus, acetylation coincides with transcriptional activation via its disruption of 
compact chromatin structure (Hebbes et al. 1988). Methylation, on the other hand, largely 
drives chromatin to its transcriptionally repressive state, although this is dependent on the 
exact residue being modified (reviewed by Zhang and Reinberg, 2001; Krebs, 2007). 
Ubiquitylation acts to activate transcription, and may also facilitate gene silencing (Henry 
et al. 2003). One specific example showcasing the interdependence of histone 
modifications was illustrated by Sun and Allis (2002), where they showed that Rad6-
mediated ubiquitylation of histone H2B in yeast facilitates methylation of lysine 4 (K4) on 
histone H3, and thus leads to transcriptional repression. Phosphorylation, another highly 
studied histone modification, typically leads to transcriptional activation. One such specific 
example can be illustrated by the known action of the Snf1 kinase, which phosphorylates 
serine 10 (Ser10) on histone H3 at INO1; this phosphorylation signals the recruitment of the 
SAGA complex to the INO1 promoter, which subsequently leads to acetylation of K14 on 
histone H3 by the SAGA acetyltransferase subunit, Gcn5 (Lo et al. 2005). This cascade of 
histone modifications at INO1 is also complemented by the action of the Ino80 and Swi-Snf 
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remodelling complexes, which act to coordinate transcriptional activation in an activator 
dependent manner (Ford et al. 2008). Such examples described here offer only a glimpse 
into the complexity and high level of coordination required to drive transcription forward in 
a eukaryotic cell that is constantly subjected to changing environmental cues. 
!
1.2 SAGA complex 
 The SAGA complex is a 2.0MDa transcriptional coactivator composed of 19 
subunits (Table 1.1). First identified for its histone acetylase activity by Grant et al (1997), 
SAGA has since been found to regulate expression of approximately ten percent of the 
yeast genome; the majority of these genes are involved in stress response (Huisinga and 
Pugh, 2004). The remaining ninety percent of RNA polymerase II-mediated transcription is 
regulated by TFIID, which plays more of a housekeeping role and acts to coordinate down-
regulation of housekeeping genes under conditions of stress (Huisinga et al. 2004). Wu et al 
(2004) determined the 3D structure of SAGA using electron microscopy, via which they 
found that the complex consists of five distinct modules (Figure 1.2a). This was confirmed 
later by Lee et al (2011) who found the same organization through a combination of mass 
spectrometry and computational methods (Figure 1.2b). The different components that 
make up these five modules are described below.  
 The first set of proteins to mention are the TATA Binding Protein Associated Factors 
(TAFs): TAF5, TAF6, TAF9, TAF10 and TAF12. Besides being present in SAGA, TAFs 
also make up a portion of TFIID. TAFs are highly conserved proteins and contribute to the 
backbone of SAGA. Interestingly, TAF5, 6, and 10 share similar spatial orientation between 
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Table 1.1: List of all identified SAGA components
SAGA Subunits
Ada1 Spt20
Ada2 Sus1
Ngg1/Ada3 Taf5
Gcn5 Taf6
Sgf11 Taf9
Sgf29 Taf10
Sgf73 Taf12
Spt3 Tra1
Spt7 Ubp8
Spt8
!8
2002) that Ada2 directly interacts with Gcn5 and Ada3, we
symbolized this direct interaction in the model by a direct
contact between Ada2 and these two proteins. Furthermore,
we positioned Ada3 in direct contact with Sgf29 based on yeast
two-hybrid data (Ito et al, 2001). Second, we positioned the
DUB module close to the SA_SPT module and located Sgf73
close to Spt20; Ubp8, Sgf11 and Sus1 were grouped together as
they depend on each other. Third, Tra1 was situated close to
Spt20, since the deletion of Spt20 led to the loss of Tra1. Spt3
was located closer to the ADA and DUB modules given that it
led to a severe synthetic growth defect with Gcn5 (Lin et al,
2008) and a negative genetic effect with Sgf11 and Sgf73
(Collins et al, 2007; Costanzo et al, 2010). All remaining
subunits of the SA_SPT module were added according to the
order of their probabilities in the respective purifications.
Fourth, for the SA_TAF module, Taf12 was placed more inside
the complex, since it exhibited higher probabilities with
members of the DUB module when used as a bait compared
with Taf5–TAP (see Taf5–TAP and Taf12–TAP in ada2D).
Yeast two-hybrid screens (Uetz et al, 2000; Ito et al, 2001;
Yatherajam et al, 2003; Yu et al, 2008; Layer et al, 2010)
furthermore identified direct interactions between the pairs
Taf5–Taf6 and Taf6–Taf9; therefore, we permitted direct
contact between these proteins in the model. Finally, for the
ADA complex, we added a contact between Ahc1 and Ahc2
based on our deletion results and yeast two-hybrid screens
(Uetz et al, 2000; Ito et al, 2001).
SGF29 is a bona fide ADA family member and
a core subunit of Gcn5/HAT complexes
During our proteomic analysis of 12 different wild-type baits,
Sgf29 was found to segregate together with components of the
HAT/Core module of the Gcn5 complexes (Figure 1B). Our
analysis on various subunit deletions of these complexes
strengthened our conclusion that Sgf29 is indeed a member of
the HAT/core module that is part of all Gcn5 HAT complexes
and not just SAGA (Figure 2A). In contrast to other well-
characterized components of the HAT complexes, Sgf29 is a
poorly characterized protein, whose deregulated expression is
implicated in malignant transformation (Kurabe et al, 2007).
Therefore, we set out to test whether the deletion of SGF29
resulted in similar phenotypes as deletion of GCN5, ADA2 or
ADA3. We first analyzed the transcriptional coactivation
capacity of the SGF29 deletion strain in order to assay for
similarities with ADA gene function (Berger et al, 1992;
McMahon et al, 2005). All ADA gene products isolated to date
are known to incorporate into the SAGA and SLIK complexes.
We assayed for the cells’ ability to survive overexpression of
Gal4-VP16, which is toxic to wild-type cells, but not lethal for
deletions in ADA components. Overexpression of VP16 has
been suggested to cause misdirection of SAGA to inappropri-
ately activate a number of cellular genes, and to sequester
general transcription factors away from productive transcrip-
tion complexes (Horiuchi et al, 1997). Mutations in SAGA that
alter functional interaction with VP16 allow the cells to
overcome the toxic growth defect and constitute an ADA
phenotype. WTand sgf29D yeast strains, along with an ada3D
strain as a control, were transformed with a high-copy plasmid
containing Gal4-VP16 (McMahon et al, 2005). Figure 5A
shows that the sgf29D strain behaved in the same manner as
the ada3D strain in this assay, suppressing VP16 toxicity
(Figure 5A). This finding indicates that Sgf29 is a functional
ADA family member, consistent with our observation that it is
part of SAGA and SLIK. The suppression of VP16 toxicity in
ADA mutants is accompanied by the inability to activate an
artificial LacZ reporter gene that is driven by Gal4-VP16
(McMahon et al, 2005). In agreement with a suppression of
VP16 toxicity, the sgf29D yeast strain was also deficient in low-
copy Gal4-VP16-dependent expression of the LacZ reporter
gene (Figure 5B), similar to other ADA family members
(McMahon et al, 2005). Overall, our biochemical analysis of
Sgf29 revealed that it behaves like a classic ADA gene, as its
deletion rescued GAL4-VP16-mediated toxicity, while also
being required for SAGA-mediated transcriptional activity
(Figure 5A and B).
Deletion of a number of SAGA subunits results in a
decreased fitness when yeast are grown on carbon sources
other than dextrose. Therefore, we decided to assay whether
deletion of SGF29 also compromised growth on various carbon
sources. We indeed found that the deletion of SGF29
phenocopied a deletion of SPT7, a SAGA subunit, resulting
in a severe growth defect when grown on plates containing
only galactose, acetate, ethanol or glycerol as the sole carbon
sources (Figure 5C). These phenotypes indicate that the
Sus1
Gcn5Ada3
Sgf73
Spt20
Spt8
Tra1
Spt7
Taf5
Taf9
Taf10
Taf12
Spt3
Sgf29
Sgf11
Sgf29
Ada2
Ubp8
Ada1
Taf6
(SAGA)
Ahc2
Ahc1
(ADA)
Gcn5Ada3
Ada2
Figure 4 Deletion interaction network and the macromolecular assembly of
the Gcn5 HAT complexes. Based upon all deletion purifications, all proteins of
the SAGA/ADA complexes were organized into modularity and consequently
a macromolecular model was assembled (for details, see main text of the
manuscript). In addition to our deletion purifications, we integrated existing data
from yeast two-hybrid and gene deletion experiments to further refine our model.
As a result, we allowed direct contacts only between protein pairs (i.e Ada2–
Gcn5; Ada2–Ada3; Ada3–Sgf29; Taf5–Taf6; and Taf6–Taf9) for which yeast
two-hybrid data exist. Genetic interaction data was also used to position some of
the proteins from different modules in close proximity. In particular, components
of the DUB module exhibit negative genetic effects with two components of the
HAT/core module, which are Ada2 and Gcn5. Therefore, these proteins were
placed in close proximity. The color code is in accordance with Figures 1B
and 2A. The size of the inset circle correlates with the molecular weight of
each illustrated protein.
Depletion analysis to build network architecture
KK Lee et al
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Figure 1.2: Schematic representation of the SAGA complex and the two dimensional 
spatial distribution of subunits. a) Determined by electron microscopy. Reprinted from 
Wu et al (2004) with permission from Elsevier: licence ID 3454440423263 (Copyright 
Clearance Centre). b) Determin d by combinatorial depletion analysis/m ss 
spectrometry and computational methods. Reprinted from Lee et al (2011) under the 
Creative Commons Attribution Licen e.
Molecular Structure of the Yeast SAGA Complex
205
Figure 6. Schematic Representation of the Localization of the SAGA
Subunits on the 3D Model of the Complex
The Taf subunits are represented in yellow and, except for Taf5,
their names were shortened to their identification number (e.g., 10
for Taf10). The extended shape of Taf5 and the positions of Taf9
Figure 5. Immunolabeling of Spt20 and Tra1, Two Core Compo- and Taf12 were inferred from previous results on TFIID (Leurent et
nents of the SAGA Complex, as well as Spt3 and Gcn5 within SAGA al., 2002, 2004), assuming that the position and subunit stoichiome-
(A) Mapping of the myc-tagged Tra1 subunit in a wild-type strain try of the Taf substructure is conserved. SAGA-specific histone fold
(L1065) with a myc-specific antibody. A specific labeled site was containing and architectural subunits are represented in purple,
identified in domain I in two distinct SAGA views (left and right whereas SAGA subunits involved in various aspects of transcrip-
panels). tional regulation are represented in orange.
(B) Mapping of Spt20 with a subunit-specific polyclonal antibody
on two distinct views of the SAGA complex.
et al., 1999b). Moreover, some of the subunits common(C) Mapping of the HA-tagged Spt3 subunit in a wild-type strain
(FY2267) with HA-specific antibody. Spt3 is located in or near the to both TFTC and SAGA, including Spt7, are not well
variable domain V in SAGA. conserved between humans and yeast (Martinez et al.,
(D) Mapping of the Gcn5 subunit with a Gcn5-specific antibody. 2001). Aside from these differences, the similarity in the
A specific labeled site was identified in domain III in two distinct
structures of TFTC and SAGA likely reflects a commonSAGA views.
mechanism for regulating transcription.(E) Schematic location of the labeled subunits within the 3D model
Insight into the core structure of SAGA was providedof SAGA.
by comparing the positions of the Taf subunits and their
interaction partners in SAGA and in TFIID. The mapping
of Taf5, Taf6, and Taf10 and subsequent alignment ofis unlikely that a particularly fragile subdomain system-
atically falls off the bona fide SAGA complex during the structures of TFIID and SAGA reveal a similar spatial
distribution of the Tafs. In Figure 6, we have noted thespecimen preparation, as was observed in some com-
plexes for domain V. In that situation both small and positions of the Tafs and extrapolated the distributions
of Taf9 and Taf12 from their location in TFIID (Leurentelongated particles should be observed with the same
frequency, which is not the case. et al., 2002). A similar extrapolation was made for Taf5
for which a 2-fold stoichiometry was determined in yeastThe structure of SAGA is strikingly similar to that of the
human TFTC complex. This conservation of structure is TFIID from electronmicroscopy and biochemical experi-
ments (Leurent et al., 2004; Sanders et al., 2002). Inconsistent with previous findings that the components
of the two complexes are conservedbetweenS. cerevis- yTFIID, theN andC termini of Taf5were found indifferent
lobes, but the two N termini were located in the sameiae and humans (Brand et al., 1999b; Martinez et al.,
1998, 2001; Ogryzko et al., 1998). Although these com- lobe and were not resolved by the mapping. The same
situation may exist in SAGA where a single labeled siteplexes share a central structure, there are differences
in the variable regions in SAGA and TFTC that may be was found with the antibody directed against the N ter-
minus of Taf5. Our data suggest the existence of a Tafattributed to the unique subunits in each complex. For
example, while TFTC contains PAF65!, Taf2, and Taf4, substructure that serves as a scaffold for SAGA assem-
bly. In TFIID, this substructure contains Taf heterodimerthose components are not conserved in SAGA (Brand
a) b)
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SAGA and TFIID, whose functions overlap at some RNA Pol II transcribed genes 
(Huisinga et al. 2004).  
 The largest subunit of SAGA is Tra1, which makes up the next class of proteins and 
occupies its own module within the complex. Tra1 is an essential gene and a member of the 
PIKK (phosphoinositide-three-kinase-related kinase) family (Saleh et al. 1998). It binds to 
acidic activators, such as Gcn4 and Gal4, providing one way of targeting the SAGA 
complex to specific promoters (Brown et al. 2001; Bhaumik et al. 2004; Reeves and Hahn, 
2005). Apart from SAGA, Tra1 is also present in the NuA4 and ASTRA complexes, as 
identified by Allard et al (1999) and Shevchenko et al (2008), respectively. Tra1 will be 
discussed later in more detail. 
 The Ada (alteration/deficiency in activation) group of proteins form the next family 
of proteins in the SAGA complex, consisting of Ada1 through 5. The Adas were originally 
identified via their suppression of toxicity as a result of GAL4-VP16 overexpression in 
yeast (Berger et al. 1992). The Ada4 subunit, known as Gcn5 (general control 
nonrepressed), was observed in 1996 by Brownell et al to possess HAT activity; this was 
initially presumed through identifying the homologous, and catalytically active p55 subunit 
of histone acetyltransferase A (HAT A) found in Tetrahymena thermophila (Brownell and 
Allis, 1995). Gcn5 contains a bromodomain, a region within transcription factors that binds 
acetylated lysines and that helps coordinate transcriptional activation (Winston and Allis, 
1999). Interestingly, the Gcn5 bromodomain is necessary for the stabilization of the Swi/
Snf remodelling complex on the promoter after Gcn5-mediated histone acetylation 
(Syntichaki et al. 2000). Gcn5, along with Ada2, Ngg1 (Ada3) and Sgf29, make up the 
!10
ADA module in SAGA, which is also present as its own entity in the nucleus (Grant et al. 
1997; Lee et al. 2011). This finding was complemented by Wu et al in 2002, who looked at 
phenotypes of different SAGA component deletions. They found that a gcn5Δspt7Δ 
phenotype is notably worse than either deletion alone, signifying that Gcn5 still exhibits 
catalytic activity outside of its association with the SAGA complex. Within the ADA 
module, Ada2 enhances acetylation by Gcn5, while Ngg1 confers lysine specificity 
(Balasubramanian et al. 2002). Ada1 plays a non-catalytic role by partially maintaining 
structural integrity of the complex (Wu and Winston, 2002). Lastly, Ada5, also known as 
Spt20, is implicated in structural maintenance of SAGA, as well as TBP binding (Sterner et 
al. 1999). It is important to note that neither Ada1 nor Ada5 are part of the ADA complex, 
as they occupy a different module within SAGA that is responsible for the maintenance of 
structural integrity (Wu and Winston, 2002; Lee et al. 2011). 
 Aside from acting as a histone-acetylase, SAGA also possesses deubiquitylation 
activity via its deubiquitylation (DUB) module. This module consists of Ubp8, Sgf11, 
Sgf73, and Sus1. Of these, Ubp8 is the catalytic subunit; in the context of SAGA, it 
catalyzes the removal of  monoubiquitin from K123 of histone H2B (Daniel et al. 2004; 
Lee et al. 2005). Deubiquitilation by Ubp8 results in K4 di- and tri-methylation at histone 
H3, a mark of active transcription (Daniel et al. 2004). In addition, it was found that Ubp8 
is required for the incorporation of Sgf11 and Sus1 into SAGA. Conversely, the association 
of Ubp8 with SAGA is dependent on Sgf11 (Shukla et al. 2006). Interestingly, Sus1 links 
SAGA to mRNA export via its interaction with the Sac3-Thp1 complex, which is a part of 
the mRNA export machinery (Rodriguez-Navarro et al. 2004).  
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 The Spt (SuPpressor of Ty) class of molecules within SAGA consist of Spt3, Spt7, 
Spt8 and Spt20 (Ada5). Initially, Spt proteins were identified as suppressors of the Ty 
transposable element insertion mutations in the LYS2 and HIS4 genes (reviewed by Winston 
and Carlson, 1992). Their functions vary within the SAGA complex. As the main focus of 
this study, Spt7 will be discussed in greater detail in the following section. In brief, its 
major role elucidated thus far is in maintaining structural integrity of the SAGA complex. 
Together, Spt3 and Spt8 make up the binding surface through which SAGA interacts with 
TBP to drive promoter-specific regulation, with the potential to facilitate both 
transcriptional activation as well as repression (Yu et al. 2003; Bhaumik et al. 2004; 
Warfield et al. 2004; Mohibullah and Hahn, 2008). However, the presence of Spt3 is 
independent of Spt8, and vice versa, and deletions in either gene result in only minor 
phenotypes (Sterner et al. 1999). On this note, it was found that Spt7 controls the 
association of Spt8 with SAGA, while Ada1 and Spt20, which also act to maintain complex 
integrity, control that of Spt3 (Wu and Winston, 2002). 
!
1.3 Spt7 
 The bulk of the work described in this thesis was focused on further elucidating the 
role of Spt7 in the context of SAGA by studying its extreme N-terminal region. As 
mentioned, Spt7 is a core component of the multi-subunit SAGA complex. The 1,332 
residue protein is critical for maintaining structural integrity of the complex alongside the 
other two core SAGA components Ada1 and Spt20. A deletion of any of these core subunits 
results in severe phenotypes in yeast and a structurally compromised complex lacking 
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specific components. In addition, Spt7 was found to regulate the levels of both Ada1 and 
Spt20, thus likely playing a role in the process through which SAGA is assembled into a 
fully functional coactivator (Wu and Winston, 2002). The importance of Spt7 is further 
exemplified by the fact that an Spt7 deletion alters the expression of approximately 10% of 
yeast genes. Wu and Winston (2002) also suggest that since Spt7 is vital for controlling the 
levels of several SAGA subunits, SAGA levels may be regulated via the regulation of Spt7 
itself. Yeast strains lacking Spt7 exhibit severe phenotypes, including the inability to grow 
on medium lacking inositol, medium containing galactose, medium lacking lysine, as well 
as medium containing ethanol (Gansheroff et al. 1995; Wu and Winston, 2002; Lee et al. 
2011). Such variety of phenotypic effects would coincide with compromising SAGA’s 
ability to function properly in response to a constantly changing cellular environment. 
 Apart from being an integral subunit of SAGA, a second C-terminally truncated 
form of Spt7, Spt7SLIK, is found in the SLIK (SAGA-like) complex. This C-terminal 
truncation results from processing which occurs between residues 1125 and 1150 (Figure 
1.3a) (Sterner et al. 2002; Wu and Winston, 2002). This processing coincides with a loss of 
the Spt8 subunit, as suggested by the alternate name for the SLIK complex; SALSA (SAGA 
Altered, Spt8 Absent). The lab of Fred Winston (2002) mapped the region responsible for 
binding Spt8 in SAGA (residues 1151-1180), the deletion of which coincides with a loss of 
binding to Spt8. It should also be mentioned that truncation of full-length Spt7 at the C-
terminus was found to facilitate formation of the SLIK complex, which coincided with the 
derepression of transcription at the HIS3 promoter under activating conditions. HIS3 is 
normally repressed by the SAGA complex; this example provides a glimpse into the 
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Figure 1.3: a) Schematic diagram of Saccharomyces cerevisiae Spt7. b) Every 
fourth residue of the first 28 residues of S. cerevisiae Spt7 is either a lysine (K) or 
arginine (R).
Histone Fold 
979-1045
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interplay between SAGA and SLIK, which aids in effectively mediating varied 
transcriptional cues as a result of environmental changes (Sterner et al. 2002). Besides 
lacking Spt8, SLIK uniquely contains Rtg2, a member of the retrograde response pathway 
in yeast. This finding potentially connects SLIK with the retrograde response pathway, 
although a direct link has yet to be established (Pray-Grant et al. 2002). Other postulated 
roles of SLIK include its involvement in the general amino acid control pathway, as strains 
subjected to amino acid starvation have been found to contain increased levels of SLIK 
(Belotserkovskaya et al. 2000). Interestingly, it was found that impairment of both the 
SAGA and SLIK complexes in combination showed an additive phenotype in comparison 
to either deletion alone. This was shown through deletion of subunits (Spt7, Rtg2, Spt8, and 
Rtg2/Spt8) unique to each complex, followed by phenotypic analysis under varying growth 
conditions (Pray-Grant et al. 2002). A third, still smaller form of Spt7 also exists, and is 
conveniently termed Spt7form3. Its function and context within which it is found is not 
known. Interestingly enough, it is as stable as the other two forms of Spt7, suggesting that it 
too carries a functional role. There is of course the possibility that Spt7form3 may represent 
an intermediate stage in the degradation process of Spt7, as suggested by Hoke et al (2007).  
 Spt7 contains a histone fold motif (residues 979-1045), through which it interacts 
with Taf10 (Gangloff et al. 2001). Spt7 also contains a bromodomain (residues 463 to 523), 
a motif which binds acetylated lysines as part of many transcription factors (Winston and 
Allis, 1999) (Figure 1.3a). A deletion in the bromodomain of Spt7, however, causes no 
detectable phenotype, and is thought to be redundant with that of Gcn5, which does in fact 
result in minor transcriptional effects upon deletion (Syntichaki et al. 2000). In addition, 
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Spt7 is highly acetylated at its lysine residues, especially around the bromodomain region, 
the functional consequences of which are unknown (Mischerikow et al. 2009). To date, the 
vast majority of research on Spt7 has been focused on its C-terminus. In addition to 
containing the site of cleavage which generates Spt7SLIK and interacts with Spt8, the C-
terminus of Spt7 has also been attributed to maintaining complex integrity via the finding 
that expressing the C-terminal 459 amino acid residues of Spt7 complements numerous 
spt7 deletion phenotypes (Wu and Winston, 2002). Interestingly, the human counterpart of 
yeast Spt7, STAF65γ, only contains the 414 amino acids homologous to the 543 residue C-
terminal region of yeast Spt7. This suggests a unique function for the N-terminus of Spt7 in 
yeast, as well as the possibility that a separate protein has adapted this role in mammalian 
cells (Wu and Winston, 2002). Deletion of STAF65γ causes many severe phenotypes, 
including destabilization of STAGA (Spt3-Taf9-Ada-Gcn5-acetyltransferase; the human 
counterpart of SAGA), deregulation of Myc-dependent genes and a loss of Spt3-dependent 
association of STAGA and core Mediator (Liu et al. 2008). 
 Overall, the role of the N-terminal portion of Spt7 has been largely unstudied. An 
N-terminal truncation lacking the first 873 amino-terminal residues of Spt7 was tested for 
growth defects in S. cerevisiae under several conditions by Wu and Winston (2002). The 
results showed a decrease in growth comparable in magnitude to that of cells carrying 
another Spt7 mutant carrying the missing 873 N-terminal residue region under several 
conditions (YPD, SC, SC -inositol). Because the paper was focused on the C-terminal 
portion of Spt7, further research to expand on the biochemical consequences of the N-
terminal truncation was not pursued (Wu and Winston, 2002). Continuing research into the 
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role(s) of yeast Spt7 by studying its N-terminus will undoubtedly further our understanding 
of how this protein functions to regulate SAGA.  
 Prior to beginning the work presented in this study, our lab discovered a potentially 
novel motif at the extreme N-terminus of Spt7. This motif contains a positively charged 
amino acid (either an arginine or lysine) at every fourth residue spanning the first 28 
residues (Figure 1.3b). It is widely accepted that positively charged residues are highly 
prevalent in lipid binding motifs (Gozani et al. 2003; Rosenhouse-Dantsker and Logothetis, 
2007). Also, it was previously found by our lab that the Ada2 subunit of SAGA binds 
phosphatidylserine (PS), hinting at the possibility for regulation of the SAGA complex 
through lipid binding (Hoke et al. 2008a). The discovery of this potentially novel lipid 
binding domain points to a yet unstudied role of Spt7, and thus a new way in which SAGA 
may be partially regulated. For this reason, my research also involved studying this 
potential lipid-binding property of the N-terminus of Spt7. 
!
1.4 Phosphatidylinositol phosphates 
 Lipids play a major role in all aspects of cellular functioning. Phosphatidylinositols 
(PtdIns), which act as key signalling molecules, are comprised of non-polar fatty acid tails 
attached to a polar inositol head group (Reviewed by Strahl and Thorner, 2005). 
Phosphorylation of the head group by numerous kinases forms the different species of 
phosphatidylinositol phosphates (PtdInsPs). In yeast, the PtdInsP species include 
PtdIns(3)P, PtdIns(4)P, PtdIns(3,5)P2 and PtdIns(4,5)P2. Each of these is generated by a 
specific kinase, except for PtdIns(4)P, which can be converted from PtdIns by three 
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different enzymes: Lsb6, Stt4 and/or Pik1 (Audhya et al. 2000; Han et al. 2001). PtdIns(4)P 
is subsequently converted to PtdIns(4,5)P2 by Mss4 (Audhya et al. 2002). PtdIns(3)P is 
enzymatically converted from PtdIns by the Vsp34 kinase (Schu et al. 1993); the 
subsequent addition of a phosphate group by Fab1 to the fifth position of the inositol ring 
generates PtdIns(3,5)P2 (Cooke et al. 1998). These two enzymes, Vps34 and Fab1, are of 
direct relevance to my work.  
 Each of these lipids plays a unique role in the cell. According to a model of 
compartmentalization as reviewed by Strahl and Thorner (2007), PtdIns(4)P is targeted to 
the Golgi and secretory vesicles leaving the Golgi. PtdIns(4,5)P2  is mostly associated with 
the plasma membrane. PtdIns(3)P localizes to the endosomal membranes and is also found 
in multivesicular bodies (MVBs). PtdIns(3,5)P2 localizes to vacuolar membranes. Although 
PtdInsPs are found in the nucleus, evidence regarding the exact species present there as 
well as the nature of their roles in contributing to transcriptional regulation remains limited 
(Martelli et al. 2001; Cocco et al. 2001; Shisheva, 2013). One study found 
phosphoinositide signalling pathways to be associated with nuclear speckles containing pre-
mRNA processing factors (Boronenkov et al. 1998). It is also valuable to note that PtdIns 
species are quickly metabolized in response to environmental changes, and thus act as 
optimal candidates in helping the cell mount an immediate response to a constantly 
changing environmental state (Dove et al. 1997; Perera et al. 2004). Since SAGA mostly 
regulates genes involved in stress response (Huisinga et al. 2004), a potential interplay 
between PtdInsPs and SAGA would provide one efficient way for the cell to adapt to 
constantly varying cellular conditions. In fact, an example of such interplay has already 
!18
been demonstrated by Han and Emr (2011), who showed that in the context of a Gal4-
compromised pathway, Tup1-repressed chromatin can be reverted to a transcriptionally 
active state by the presence of PtdIns(3,5)P2 at the late endosome and vacuolar membranes. 
The Tup1-Cyc8 co-repressor complex is recruited by the lipid along with Cti6, resulting in 
their fusion and switch to the Cti6-Cyc8-Tup1 coactivator complex. The coactivator is then 
shuttled into the nucleus and subsequently interacts with SAGA to drive transcription at the 
GAL1 promoter (Han and Emr, 2011). A separate study demonstrated that the localization 
of Pik1, the phosphatidylinositol 4-kinase, was dependent on the presence of nuclear 
PtdIns(4)P (Strahl et al. 2005). Such evidence links the dynamic role of PtdIns molecules to 
nuclear processes, presenting an exciting avenue of research. In this light, a portion of my 
thesis was focused on discovering the implication of Spt7’s potential lipid binding ability, 
and the implications associated with such function.  
!
1.5 Tra1 
 The final aspect of my thesis was focused on helping determine the mechanism of 
suppression of a FATC domain mutant of Tra1 (Tra1-F3744A) by a Tti2 allele harbouring a 
phenylalanine to serine mutation at position 328 (Tti2-F328S). Tra1 is an essential 433kDa 
protein which directly binds to acidic activators such as Gal4 and Gcn4 to facilitate 
transcriptional activation by targeting SAGA to specific promoters (Brown et al. 2001; Qiu 
et al. 2005). As previously mentioned, it is also part of the NuA4 and ASTRA complexes 
(Saleh et al. 1998; Allard et al. 1999; Shevchenko et al. 2008). It is part of the PIKK 
(phosphoinositide-three-kinase-related kinase) family of proteins, although it does not 
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possess kinase activity (McMahon et al. 1998; Saleh et al. 1998; Abraham, 2004). This is 
due to the lack of ATP binding residues required for enzymatic function (Saleh et al. 1998; 
Bosotti et al. 2000; Mutiu et al. 2007).  
 It has been a long term objective of the Brandl lab to determine the role of Tra1 in 
the cell. Such knowledge would not only be useful for further understanding of 
transcriptional regulation and protein dynamics in yeast, but would also be highly relevant 
in shedding light on Tra1’s human homolog, TRRAP (TRansformation/TRanscription 
domain-Associated Protein). TRRAP is important in that it regulates the transcription of 
genes involved in oncogenesis by direct interaction with transcription factors such as Myc 
and E2F (McMahon et al. 1998). Tra1’s multiple domains include 40-50 N-terminal HEAT 
domain repeats, a 300 residue PI3K domain further downstream, followed by a 500 residue 
FAT (FRAP, ATM, TRAP) region as shown in Figure 1.4. At the very extreme C-terminus 
is the FATC (FRAP, ATM, TRAP, C-terminus) domain, which is thought to regulate the 
catalytic activity of the PI3K domain. One such instance has been illustrated in the context 
of mTOR, where the FATC domain of the protein was shown to loop back and contact the 
PI3K domain (Takahashi et al. 2000; Sturgill and Hall, 2009; Yang et al. 2013). Another 
interesting example where the C-terminus loops back to interact with the rest of the protein 
can be found in mammalian DNA-PKc, where the C-terminus interacts with its N-terminal 
region upon DNA binding to regulate kinase activity (Rivera-Calzada et al. 2005). Unlike 
Spt7, Tra1 is not necessary for maintaining structural integrity of the SAGA complex, as 
shown by Helminger et al. (2011) in the context of Schizosaccharomyces pombe; a tra1 
knockout mutant is lethal in Saccharomyces cerevisiae. 
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Figure 1.4: a) Modular structure of Tra1/TRRAP. The Protein Databank Code is shown 
below each modular structure b) Alignment of domains between Tra1 and TRRAP. Dark 
grey rectangles represent regions of disorder, and light grey sections represent non-
repeating regions. ID, identity. Reprinted from Knutson and Hahn (2011) with the 
permission of the American Society of Microbiology.
!21
 A lack of kinase activity by Tra1 raises the question as to the role of the FATC 
domain. Given that the domains of PIKK proteins are highly conserved, the FATC region of 
Tra1 is likely important in another aspect of its function. At the time of my studies, the 
precise position of the FATC domain was unknown, as the crystal structure of the C-
terminal domains of mTOR has only recently been determined (Yang et al. 2013). In their 
publication, Yang et al (2013) show that the FATC domain folds back to interact with the 
activation loop of the PI3K domain. Prior to this discovery however, multiple potential 
roles had been proposed for the FATC domain. For example, several studies have 
implicated the C-terminus of Tra1 in interaction with other proteins. Park and colleagues 
(2001) showed that upon deletion of the C-terminus of the human homologue TRRAP, 
Gcn5 binding was lost and HAT activity was abolished. Likewise, studies in other PIKK 
family members have found the C-terminus to be important in facilitating interaction with 
other proteins. The FATC domain of Mec1 is needed to interact with Rfa1 and Rfa2 
(replication protein A components), driving its recruitment to sites of DNA damage 
(Nakada et al. 2005). Previous studies examining the role of the FATC domain of Tra1 have 
found that mutations in this region result in slow growth and in cases, inviability of the cell. 
For example, Hoke et al (2010) showed that an addition of a single glycine residue to the 
C-terminal end of the domain resulted in loss of cellular viability. Other mutations in the 
FATC region, such as a change from a leucine to alanine at position 3733 (Tra1-L3733A) 
results in slow growth and changes in transcription under stressful conditions (Kvas, 2012). 
This particular L3733A mutation was rescued by a loss of nonsense mediated decay 
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(NMD), a process which identifies premature stop codons on mRNA in the cell (Muhleman 
et al. 2008).  
 Our lab has generated mutants of the FATC domain of Tra1 in an effort to 
understand its function (Hoke et al. 2010). Several mutants of interest were found, one of 
which contained a phenylalanine to alanine change at the terminal FATC residue 3744 
(Tra1-F3744A). This mutant showed several effects, including slow growth under various 
conditions, transcriptional defects, mild effects on SAGA-targeted acetylation, and protein 
stability (Genereaux et al. 2012). Such results suggest a broad importance of the FATC 
domain on Tra1 function. However, the exact role was yet to be determined. In an effort to 
uncover this role, our lab set out to identify suppressor mutations that rescue the growth 
defects associated with Tra1-F3744A. Following next-generation sequencing using the 
ABI-SoLID4 platform, it was discovered that a phenylalanine to serine mutation in residue 
328 of Tti2 (Tti2-F328S) suppressed tra1-F3744A. The level of suppression of Tti2-F328S 
was slightly better than that of another Tti2 allele harbouring an isoleucine to phenylalanine 
mutation at position 336 (Tti2-F336I), and was thus pursued further (Figure 1.5). 
Interestingly, Tra1 and Tti2 are both components of the putative ASTRA complex 
(ASsembly of Tel, Rvb, and Atm-like kinase), making the suppression of Tra1-F3744A by 
Tti2-F328S that much more intriguing (Shevchenko et al. 2008). 
!
1.6 Tti2  
 Tti2 (Tel two interacting protein 2) is also part of the triple-T complex, alongside 
Tti1 and Tel2 (Hurov et al. 2010). It is thought that the complex aids in the biogenesis and 
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Figure 1.5: Suppression of Tra1-F3744A by Tti2-F328S (SUP3) and Tti2-I336F 
(SUPB). Yeast strains carrying wild-type Tra1 (CY4353), Tra1-F3744A (CY4350), 
Tra1-F3744A/Tti2-F328S (CY5667), and Tra1-F3744A/Tti2-I336F (CY5842) 
containing YCplac33-YHR100C were serially diluted and spotted onto YPD at 30℃, 
37℃, and YPD containing 6% ethanol at 30℃ (Genereaux et al. 2012). Reprinted from 
Genereaux et al (2012) with permission from the Genetics Society of America: licence 
ID 3456110806992 (Copyright Clearance Centre).
30℃ C37℃ 6% ethanol
!24
maturation of PIKKs, based on evidence that it binds newly synthesized proteins and thus 
acts in the maintenance of protein stability (Takai et al. 2007; Horejsi et al. 2010). To aid in 
determining the mechanism of suppression of Tra1-F3744A by Tti2-F328S, I set out to 
examine the effect of Tra1-F3744A on the protein localization within yeast cells using 
fluorescence microscopy. My aim was also to analyze the localization of both wild-type and 
Tti2-F328S, but most importantly whether the suppressor mutation in Tti2 would rescue 
any mislocalization observed with the Tra1-F3744A mutant. Such analysis would help in 
pinpointing the nature of suppression by the Tti2-F328S allele, and thus provide a narrower 
understanding of the role of the FATC domain in the context of Tra1, as well as SAGA 
function. 
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1.7 Thesis Overview 
 The N-terminus of Spt7 has been largely unstudied. Based on our initial 
observations of decreased growth of strains carrying N-terminally truncated Spt7 mutants, 
as well as our finding of a potential novel lipid binding domain at the extreme N-terminus, 
I hypothesized that the N-terminus of Spt7 is crucial in the regulation of the SAGA 
complex, and that this regulation is partly achieved via Spt7’s lipid binding function. 
 To test my hypothesis, I examined the effects of a 1-121 amino terminal truncation 
mutation (Spt7121-1332) on protein expression, growth, transcriptional activation, histone 
acetylation at lysine 18 of histone H3 (H3K18) of PHO5, interaction with the Tra1 and 
Gcn5 SAGA subunits, as well as localization using eGFP-tagged versions of wild-type and 
truncated Spt7 mutants under normal growth and stress conditions. I found that the N-
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terminal truncation affected expression, as well as growth levels and transcriptional 
activation at SAGA-targeted promoters. In addition, the Spt7121-1332 mutant caused a partial 
decrease in acetylation at H3K18. However, interaction of Spt7 with both Tra1 and Gcn5 
remained unaltered in context of the Spt7121-1332 truncation protein. Likewise, neither the 
Spt773-1332 nor the Spt7121-1332 mutant caused mislocalization away from the nucleus under 
normal growth condition or conditions of stress. 
 Interestingly, Hoke et al. (2008a) found that Spt7 bound lipid. I mapped the region 
of binding to a putative N-terminal lipid binding domain characterized by the presence of a 
pattern of repeating positively charged residues. The 1-73 amino terminal fragment bound 
to PtdIns(3)P and PtdIns(3,5)P2, which was abrogated as a result of mutating the first four 
positively charged residues to glutamines (R4QK8QR12QK16Q). The double mutant 
R4QK8Q also resulted in a loss of binding to both lipid species, while binding by the 
R12QK16Q mutant was unchanged. These mutants, especially Spt7-R4QK8Q, showed minor 
effects on growth under numerous conditions, suggesting a functional importance to the 
lipid binding of Spt7. Localization of eGFP-wild-type versus eGFP-Spt773-1332 and eGFP-
Spt7121-1332 mutants was also tested in strains lacking PtdIns(3)P (vps34 null strain) and 
PtdIns(3,5)P2 (fab1 null strain) to determine whether the absence of these specific lipid 
species would affect localization of Spt7. Interestingly, the cellular distribution of eGFP-
Spt7 differed in the two strain backgrounds. 
 I also analyzed how Tra1 localization is affected as a result of the F3744A mutation, 
and more importantly what effect the Tti2-F328S suppressor has on the cellular distribution 
of Tra1 to help determine how the FATC domain of Tra1 regulates its function. My part in 
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determining the nature of suppression of the Tra1-F3744A FATC mutant by Tti2-F328S 
involved performing fluorescence microscopy. I first tracked the localization of eGFP-
tagged wild-type Tti2 and Tti2-F328S, both of which showed nuclear as well as 
cytoplasmic signal; localization to foci at the vacuolar membrane was more pronounced in 
context of growth in SC medium containing 6% ethanol. eGFP-Tra1-F3744A showed 
partial mislocalization to cytoplasmic foci. The precise nature of these foci could not be 
determined with confidence, as a general overlap with numerous RFP-tagged membrane 
components was observed. However, the presence of Tti2-F328S lessened the 
mislocalization effect of Tra1-F3744A, suggesting that this mutation may partly reverse 
Tra1-F3744A’s increased affinity for cytoplasmic membrane components.  
 Overall, the goal of my thesis was to further our understanding of how Spt7, 
namely its N-terminal region, regulates the functioning of the SAGA complex in 
Saccharomyces cerevisiae. In addition, I sought to aid in determining how Tti2 
regulates Tra1 function via studying Tti2 and Tra1 through the use of fluorescence 
microscopy. Future research needs to be done to determine precisely how Tti2 acts to 
regulate the FATC domain of Tra1, and what implication this regulation has on structure/
function of the protein. Similarly, the importance of the extreme N-terminus of Spt7 on 
SAGA function is intriguing. Learning more about how this lipid binding affects Spt7, as 
well as the regulation of SAGA, could potentially uncover new angles through which we 
look at, and approach the complex topic of protein complex assembly and/or transcriptional 
regulation in the cell. 
!
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Chapter 2: Materials and Methods 
2.1 Saccharomyces cerevisiae strains 
All S. cerevisiae strains used in this study are listed in Table S1 of the Appendix. 
CY4367, CY4359, CY4384, and CY4385 were engineered by transforming the spt7 
knockout strain FY1093 (MATa spt7-402::LEU2 his4-917-lys2-173R2 leu2-1 ura3-52 
trp1-63 ade8) with DNA constructs CB2157 (single-copy Spt7WT), CB2154 (single-copy 
Spt7121-1332), CB2162 (multi-copy Spt7WT), and CB2161 (multi-copy Spt7121-1332), 
respectively. These strains were used to test for protein expression levels. In addition, 
FY1093, CY4385, CY4367, as well as CY5616 were used to test for growth phenotypes 
and acetylation at lysine 18 of histone H3; CY5616 was made by transforming FY1093 
with CB2216 (multi-copy Spt773-1332). These strains were selected for via growth in 
medium lacking leucine (spt7 disruption marker) and tryptophan (plasmid maintenance).  
BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) was transformed with DD37 
(multicopy myc9-Spt71-120 fragment) to generate the CY6161 strain, which was used to test 
for growth phenotypes; growth was done in minimal medium lacking uracil to ensure 
plasmid maintenance. Strains carrying LacZ-constructs tested in this study were made by 
transforming DNA constructs CB1503 (LacZ-PHO5), CB1476 (LacZ-INO1), CB2112 
(LacZ-SRE element) and CB1533 (LacZ-RPL53A) into CY4465 to generate CY5633, 
CY5634, CY5834 and CY6071. Note that CY4465 is isogenic to FY1093, except that the 
spt7 knockout leu2 marker was switched to ura3.  
Strains CY6132 and CY6139 were used in the Tra1-Spt7 immunoprecipitation assay. 
These were made by transforming CY5871 with CB1779/CB2288 (single-copy flag3-Tra1/
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single copy myc9-Spt7WT) and CB1779/CB2293 (single-copy flag3-Tra1/multi-copy myc9-
Spt7121-1332), respectively. Plasmid maintenance was selected for via growth in minimal 
medium lacking leucine (spt7 knockout marker), tryptophan (flag3-Tra1 maintenance) and 
uracil (myc9-Spt7 maintenance). CY5871 represents a spt7 knockout in consortium 
background, and was engineered by crossing FY1093 with BY4741/BY4742, dissected by 
Dr. Brandl and selected for trp- spore colonies. To generate control strains CY6110 and 
CY6108 for the Tra1-Spt7 pull-down assay, CB1779 and CB2288 constructs were 
separately transformed into CY5871, respectively.  
To test for Gcn5-Spt7 interaction, CY6099 and CY6308 strains were generated by 
transforming DD31/DD33 (single-copy flag3-Spt7WT/multi-copy myc9-Gcn5) and DD39/
DD33 (multi-copy flag3-Spt7121-1332/multi-copy myc7-Gcn5), respectively.  
In order to test for localization of Spt7 using fluorescence microscopy, yeast strains 
CY6079, CY5922, and CY5921 were made by transforming BY4741 (MATa his3Δ1 leu2Δ0 
lys2Δ0 ura3Δ0) with CB1966 (eGFP-Spt7WT), DD29 (eGFP-Spt773-1332) and DD28 (eGFP-
Spt7121-1332), respectively.  
To test for lipid-binding of N-terminal fragments of Spt7, Escherichia coli Rosetta 
strain (Novagen, Inc.) was transformed with N-terminal 1-73 residue fragment mutants 
DD13 (GST-Spt7-R4QK8Q), DD14 (GST-Spt7-R12QK16Q), and DD7 (GST-Spt7-
R4QK8QR12QK16Q). Rossetta strain was also transformed with DD6 to express the wild-
type Spt71-73 fragment. To test for growth of these mutants, CY4465 was transformed with 
full-length equivalents of these N-terminal mutations DD19 (full-length Spt7-R4QK8Q), 
DD20 (full-length Spt7-R12QK16Q) and CB2279 (full-length Spt7-R4QK8QR12QK16Q) to 
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generate CY5798, CY5795 and CY5797 respectively. CB2157 was used as the Spt7WT 
carrying construct to generate CY5796.  
The fab1 knockout strains CY6085, CY6087, and CY6086 carrying eGFP-Spt7WT 
(CB1966),  eGFP-Spt773-1332 (DD29), and eGFP-Spt7121-1332 (DD28) were made by crossing 
the CY5871 strain with a fab1 deletion strain (Open Biosystems). Diploid strains were 
sporulated and dissected by Dr. Brandl, and selected for tetrads that grew in the presence of 
G418 (fab1Δ marker) and minimal medium lacking leucine (spt7Δ marker). The vps34 
deletion strains carrying eGFP-wild-type Spt7 (CY6089),  eGFP-Spt773-1332 (CY6091), and 
eGFP-Spt7121-1332 (CY6090) were generated in identical fashion. BY4741 strains CY5854 
and CY6062 containing eGFP-wild-type-Tti2 and eGFP-Tti2-F328S were made by Dr. 
Brandl to test for localization of Tti2.  
Diploid yeast strains containing eGFP-Tra1/Tra1 Tti2/Tti2 (CY6029), eGFP-Tra1-
F3744A/Tra1 Tti2/Tti2 (CY6025), and eGFP-Tra1-F3744A/Tra1 Tti2-F328S/Tti2 
(CY6063) were also generated by Dr. Brandl via mating of BY4741 with a strain 
containing integrated GFP-tagged Tra1 (wild-type or F3744A mutant). Strains containing 
RFP-tagged membrane components in the EY0987 background (MATα his3D1 lys2D0 
ura3D0; Huh et al. 2003), kindly provided by Peter Arvidson, were made by crossing with 
CY6018 strain carrying eGFP-Tra1-F3744A/Tti2. 
!
2.2 DNA constructs 
All DNA constructs and oligonucleotides used in this study are listed in Table S2 and 
S3 of the appendix, respectively. LacZ-PHO5 (CB1503) and LacZ-INO1 (CB1476) 
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constructs were from Mutiu et al. 2007. The LacZ-SRE element containing construct 
(CB2112) was made from a HIS3 promoter regulated by two SRE (stress responsive) 
elements in place of the Gcn4 binding site, as described by Hoke et al. (2010). The RPL35A 
promoter was made by PCR with oligonucleotides 3203-1 and 3203-2, and cloned into 
CB1503 using BamHI/HindIII to generate the LacZ-RPL35A DNA construct, CB1533. All 
LacZ-promoter fusions were expressed on the LEU2 centromeric plasmid YCp87 (Brandl 
et al. 1993).  
CB2157 (single-copy Spt7WT) was made by cloning full-length Spt7 NotI/EcoRI 
fragment into YCplac22 single-copy vector carrying trp+ marker and a myc9 tag. CB2154 
(single-copy Spt7121-1332) was expressed from the same vector, but cloned into full-length 
Spt7 carrying plasmid using NotI/NcoI fragment starting at the N-terminal amino acid 
residue 121. This fragment was generated via PCR using primers 5741-1 and 5741-2. 
CB2162 (multi-copy Spt7WT) was made by subcloning NotI/EcoRI full-length Spt7 into 
YEplac112 multi-copy vector also carrying trp+ marker and a myc9 tag. CB2161 (multi-
copy Spt7121-1332) was cloned into the same plasmid carrying wild-type Spt7 via NotI/NcoI 
to delete the base pairs coding for the first 121 amino terminal residues.  
The eGFP-Spt773-1332 and eGFP-Spt7121-1332 constructs were engineered by cloning 
pieces of CB2215 and CB2161, respectively, into YCplac33 expressing eGFP from a DED1 
promoter using NotI/SstI; eGFP was generated via PCR using oligonucleotides 5077-1 and 
5077-2. CB2288 (multi-copy Spt7WT) and CB2293 (multi-copy Spt7121-1332) constructs used 
in the Tra1-Spt7 pulldowns were expressed on YEplac195 multi-copy ura+ myc9-carrying 
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plasmid. Cloning into this plasmid was performed using NotI/EcoRI fragments from 
CB2157 (Spt7WT) and CB2161 (Spt7121-1332).  
The flag3-Tra1 (CB1779) was cloned using NotI/SstI fragment of Tra1 and ligated into 
YCplac22 trp+ single-copy flag3-expressing vector. To determine Gcn5-Spt7 interaction, 
this same vector (YCplac22) was used to generate DD31 (single-copy Spt7WT) via 
subcloning of the NotI/EcoRI piece of CB2157. DD39 was cloned (Spt7121-1332) via triple 
ligation (PstI/NotI and NotI/EcoRI) into YEplac112 trp+ flag3-multicopy expressing 
plasmid. DD33 (multi-copy Gcn5) was cloned NotI/SstI into YEplac195 ura+ myc9-
multicopy vector.  
The GST-Spt7-R4QK8Q (DD13), R12QK16Q (DD14), and R4QK8QR12QK16Q (CB2279) 
1-73 N-terminal mutant fragments were expressed on pGEX-KGT vector (kindly provided 
by Eric Ball), and cloned using BamHI/EcoRI. Spt7-R4QK8Q mutant was generated via 
PCR using primers 5939-1 and 5799, while the R12QK16Q mutant was made by primers 
5939-2 and 5799. The quadruple mutant R4QK8QR12QK16Q was generated by PCR using 
primers 5914-1/5914–2, and triple ligated into CB2157 using NotI/EcoRI and NcoI/EcoRI. 
DD19 and DD20 represent full length Spt7 carrying R4QK8Q, and R12QK16Q mutations, 
respectively. Template for PCR was a 1441bp intermediate molecule of Spt7 cut HindIII/
HindIII out of CB2157 (Spt7WT). After mutagenic amplification of this piece using 
oligonucleotides 6001-1/5741-2 (R4QK8Q), and 6001-2/5741-2 (R12QK16Q), pieces were 
cloned into CB2157 using NotI/NcoI.  
To generate the full-length Spt7-R4QK8QR12QK16Q carrying mutant, DD7 (1-73 amino 
terminal coding Spt7-R4QK8QR12QK16Q fragment) was sub cloned into DD18 (1441bp 
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portion of CB2157) via HindIII/HindIII, followed by subsequent cloning of this fragment 
into full length Spt7 (CB2157) using triple ligation NotI/NcoI - NcoI/EcoRI. eGFP-tagged 
Tti2, Tti2-F328S, Tra1 and Tra1-F3744A constructs were engineered as described in 
Genereaux et al (2012). RFP-tagged membrane constituents were generated as described in 
Huh et al (2003). 
!
2.3 Growth assays 
Yeast strains were grown to stationary phase in either synthetic dropout media 
(composed of yeast nitrogen base, glucose, and the appropriate amino acid dropout mixture 
for strain/plasmid selection) or YPD (a combination of yeast extract, peptone, and glucose 
to provide a rich growth medium). Four 10-fold dilutions were made, and 4µl of each was 
spotted onto the various media: YPD, medium lacking inositol, YPD containing 4% and 6% 
ethanol, galactose, 1.2M NaCl, and low phosphate medium. All cultures were grown at 
30ºC, with the exception of cells grown on YPD medium at 37ºC to test for temperature 
sensitivity. 
!
2.4 β-galactosidase assays 
LacZ assays were performed using the spt7 knockout strain FY1093 carrying the 
following LacZ-promoter fusions on plasmids: LacZ-PHO5 (CB1503), LacZ-INO1 
(CB1467), LacZ-SRE/HIS3 (CB2112), and LacZ-RPL35A as the positive control 
(CB1533). These strains were transformed with the various Spt7 constructs, including wild-
type Spt7, Spt773-1332 and Spt7121-1332. All strains were grown to saturation in synthetic 
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dropout (SD) medium, washed 3 times with 3ml of sterile water, and grown in appropriate 
medium for 16 hours. The strain carrying the LacZ-PHO5 construct on a LEU2 centromeric 
plasmid was grown in YPD depleted of phosphate. The strain carrying LacZ-INO1 was 
grown in medium lacking inositol. The strain carrying LacZ-SRE/HIS3 was grown in 6% 
ethanol and was made from HIS3 promoter regulated by two SRE (stress responsive) 
elements in place of the Gcn4 binding site as described by Hoke et al. (2010). β-
galactosidase assays were performed as previously described by Hoke et al. (2010).  
Activity for each promoter was measured in triplicate. 
!
2.5 Chromatin immunoprecipitation 
 ChiP assays were performed using anti-H3 (Abcam, Inc ab1791) and anti-AcH3K18 
(ab1191), as described by Mutiu et al. (2007). Since acetylation at the PHO5 promoter was 
being measured, strains CY4367, CY5616, CY4385, and FY1093 were grown in YPD 
depleted of phosphate. Normalization of input chromatin was done by PCR using 
oligonucleotides flanking the PHO5 gene; 6095-1 and 4987-2. Levels of 
immunoprecipitated PHO5 promoter were determined using AlphaImager 3400 software 
(Alpha Innotech, San Leandro, CA) after separation of PCR products (in triplicate) by 
electrophoresis and ethidium bromine straining. The ratios of the acetylated H3K18 to total 
histone H3 were calculated as a percentage of the wild-type strain. The same assay was 
repeated using PGK1 oligonucleotides 2927-1 and 2927-2, in which case the strains were 
grown in YPD. 
!
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2.6 Western blotting 
Yeast extracts were prepared from CY4367 (cen myc9-Spt7WT), CY4359 (cen myc9-
Spt7121-1332), CY4384 (2µ myc9-Spt7WT) and CY4385 (2µ myc9-Spt7121-1332) by glass bead 
lysis (Brandl et al. 1993) to test for expression. Protein concentration was measured using 
the Bio-Rad Protein Assay (Bio-Rad) to ensure consistent loading between samples. 
Following separation by SDS-PAGE, Western blots were performed using PVDF 
membranes (Roche) as previously described by Mutiu et al. (2007).  All flag-tagged 
proteins were detected using anti-flag (M2; Sigma-Aldrich) primary antibody at a dilution 
of 1:4000. All myc-tagged proteins were detected using anti-myc (9E10; Sigma Aldrich) 
primary antibody at the same dilution. Blots were subsequently probed with secondary anti-
mouse antibody (IgG HRP conjugate; Promega) at a dilution of 1:10,000. Scanning of films 
was performed using the AlphaImager 3400 software (Alpha Innotech). 
!
2.7 Immunoprecipitation 
 After growth of CY6132 (cen flag3-Tra1 + cen myc9-Spt7WT) and CY6139 (cen flag3-
tra1 + 2µ myc9-Spt7121-1332) S. cerevisiae strains to OD600 ~2.0, extracts were lysed via 
grinding in liquid nitrogen (Saleh et al. 1997). Tra1-Spt7 immunoprecipitation was 
performed using anti-flag M2 magnetic beads (Sigma-Aldrich), as described by DaSilva et 
al (2013), using 2.5mg of protein extract. To elute, 60µl of 2X SDS loading buffer was 
added to each tube followed by boiling at 95ºC for two minutes. Eluent was then 
transferred to clean Eppendorf tubes, and 20µl of each was loaded onto 5% and 12.5% 
polyacrylamide gels to blot for flag3-Tra1 and myc9-Spt7, respectively. Prior to performing 
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the assay, a Western blot was done to normalize the amount of wild-type Spt7 to that of 
Spt7121-1332. 
!
2.8 Gel filtration chromatography 
Yeast strains CY6099 (cen flag3-Spt7WT + 2µ myc9-Gcn5) and CY6308 (2µ flag3-
Spt7121-1332 + 2µ myc7-Gcn5) were grown up to OD600 ~2.0, and lysed by grinding in liquid 
nitrogen (Saleh et al. 1997). Extract was prepared in IPP150 buffer (10mM Tris-HCl 
pH8.0, 150mM NaCl) and 2mg of extract was applied over FPLC Superose 6 HR10/30 
column (Amersham Biosciences) at a flow rate of 0.3 ml/min, as described by DaSilva et al 
(2013). Following washing with elution buffer (0.05M 1M NaPhosphate solution, 0.15M 
NaCl), selected fractions were resuspended in SDS loading buffer and separated on an 8% 
SDS-polyacrylamide gel. A Western blot was performed using anti-myc antibody (9E10; 
Sigma Aldrich) to detect for the presence of myc9-gcn5 (CY6099) and myc7-Gcn5 
(CY6308), which were loaded as alternating fractions. 
!
2.9 Fluorescence microscopy 
Yeast cells expressing eGFP and/or RFP fusions were grown in synthetic complete 
medium then diluted 1:4 into synthetic complete medium with or without 8% ethanol. 
Growth in ethanol was for 18 hours. Prior to visualization, cells were concentrated 10-fold 
and 4’6-diamidino-2-phenylindole (DAPI) was added to 0.02 mg/mL. Fluorescent images 
were obtained using a Zeiss Axioskop 2 microscope (at an overall magnification of 630x) 
driven by ImageJ 1.41 software (National Institutes of Health) and a Scion CFW 
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Monochrome CCD Firewire Camera (Scion Corporation, Frederick Maryland) using DAPI, 
RFP and GFP filter sets. Quantification of GFP-signal intensity was performed using 
ImageJ software (version 1.45). The freehand selections tool was used to trace each whole 
cell and nucleus separately. The measure function was used to output the signal intensity 
per unit area for each selection. To correct for background noise, the average intensity of 
three background selections adjacent to each cell was subtracted from the signal intensity 
measured for any cell given. The corrected nuclear intensity was then divided by the 
corrected whole cell intensity to give a nuclear to cell intensity ratio. The mean from 20 
cells was calculated plus/minus a standard deviation (Genereaux et al. 2012). 
!
2.10 Lipid overlay assays 
Expression of GST-tagged N-terminal Spt7 (Spt71-439, Spt71-121, Spt71-73) peptides, as 
well as the Spt7-R4QK8Q, Spt7-R12QK16Q, and Spt7-R4QK8QR12QK16Q mutants was 
induced via addition and overnight growth in the presence of 0.5mM IPTG at 15℃, 
followed by purification using a GST-column and elution with 25mM glutathione (pH 8.0).. 
Lipid-binding assay was performed as described by Hoke et al (2008a), except that 200µg 
of protein was loaded onto PIP-strips (Echelon biosciences). Lipid-binding was detected by 
blotting with anti-GST antibody (Upstate) at a dilution of 1:4000 and secondary anti-mouse 
antibody conjugated to horse radish peroxidase (Promega) at 1:10000.  
!
!
!
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Chapter 3: Results  
3.1 Lack of the N-terminal 121 residues of Spt7 results in decreased protein expression 
The Winston lab previously found that an Spt7 truncation mutant lacking the first 873 
N-terminal residues decreased cellular growth under condition of stress, including medium 
lacking inositol. I therefore set out to compare the growth of wild-type Spt7 to two N-
terminally truncated mutants (Spt773-1332 and Spt7121-1332) under different conditions. Prior 
to testing for growth defects, it was necessary to determine if the N-terminal truncation 
mutants were expressed at comparable levels to that of wild-type Spt7. I engineered single 
copy (cen) and multicopy (2µ) plasmids carrying full length myc9-tagged wild-type or 
Spt7121-1332. After these constructs were transformed into the spt7 knockout yeast strain 
FY1093, expression levels were checked by Western blot analysis using α-myc antibody 
following separation by SDS-PAGE. Spt7121-1332 expressed on a centromeric plasmid 
showed a notable decrease in levels compared to that of wild-type Spt7 also carried on a 
cen plasmid. Thus, a lack of the first 121 amino terminal residues decreased protein levels 
of Spt7. This decrease in protein expression was compensated for by expressing Spt7121-1332 
on a multi-copy (2µ) plasmid, resulting in comparable protein levels to the wild-type 
expressed on a centromeric plasmid (Figure 3.1). Expression of the Spt773-1332 mutant 
protein was also tested, and showed similar levels compared to Spt7121-1332 (data not 
shown). In addition, Figure 3.1 showed no differences in expression between either of the 
lower-weight forms of Spt7 (Spt7SLIK or Spt7form3) when the wild-type (cen) and Spt7121-1332 
(2µ) levels were compared. It should be noted however that Spt7121-1332 produced a greater 
quantity of protein fragments that ran below the molecular weight of Spt7form3 as compared 
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Figure 3.1 Comparing expression levels of Spt7WT and Spt7121-1332. Yeast strains 
expressing myc9-tagged wild-type (CY4367) or N-terminally truncated Spt7121-1332 
(CY4359) from centromeric plasmids were grown to mid-log phase in minimal 
medium. Likewise, yeast strains expressing myc9-tagged wild-type (CY4384) or N-
terminally truncated Spt7121-1332 (CY4385) from multi-copy (2µ) plasmids were grown 
to mid-log phase in the same medium. Crude cell lysates were obtained, two-fold serial 
dilutions were separated by SDS-PAGE and Western blotted with α-myc Ab. a) 
Increasing dilutions of Spt7WT and Spt7121-1332 expressed from a centromeric plasmid b) 
Comparing expression of myc9-tagged Spt7WT from a centromeric plasmid versus 
Spt7121-1332 from a 2µ plasmid.
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to the wild-type protein (Figure 3.1).      
!
3.2 N-terminal truncations of Spt7 decrease growth under various conditions 
Prior to determining specific functions of the N-terminal region of Spt7, it was 
important to test for general effects of Spt773-1332 and Spt7121-1332. I tested for the ability of 
wild-type (on a cen plasmid) and Spt7 deletions (on a 2µ plasmid) to grow on various media 
(Figure 3.2). Serial dilutions of strains CY4367 (spt7 knockout carrying myc9-wild-type 
Spt7 on a centromeric plasmid), CY4385 (spt7 knockout carrying myc9-Spt7121-1332 on 2µ 
plasmid), CY5616 (spt7 knockout carrying myc9-Spt773-1332 on 2µ plasmid), and FY1093 
(spt7 knockout, kindly provided by Fred Winston) were spotted onto the following media: 
YPD (at 30º and 37º), YPD containing low phosphate, YPD containing 4% and 6% ethanol, 
YP containing galactose as the carbon source, YPD containing 1.25M NaCl, and medium 
lacking inositol. Both truncations decreased growth under all tested conditions (Figure 
3.2a). Some conditions however, such as medium lacking inositol, YPD containing 6% 
ethanol, and YPD containing 1.25M NaCl resulted in a more pronounced growth defect, 
which was comparable to that of the spt7 knockout strain. Interestingly, growth at 37ºC 
resulted in a more severe growth defect in context of both Spt773-1332 and Spt7121-1332 
truncation mutants than the knockout. 
Given the decrease in growth due to the lack of the first 73 or 121 amino terminal 
residues, I asked whether expression of a fragment carrying the first 120 N-terminal amino 
acid residues (Spt71-120) would affect growth in the context of a wild-type strain. BY4742 
(containing wild-type Spt7) was transformed with myc9-tagged wild-type Spt71-120 
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Figure 3.2 Phenotypes of N-terminal truncations of Spt7. a) Spt7 deletion strain 
FY1093 was transformed with full-length wild-type Spt7 expressed on cen plasmid. 
The Spt773-1332, and Spt7121-1332 truncated-Spt7 mutants were expressed on 2µ plasmids. 
Saturated cultures were serial diluted and spotted onto YPD plates (30°C and 37°C), 
4% and 6% ethanol, medium lacking inositol, low phosphate, galactose medium, and 
1.2M sodium chloride.  b) KY320 strain was transformed with an N-terminal wild-type 
1-120 residue fragment of Spt7 expressed on a 2µ plasmid. Strains either carrying (+ 
1-120) or lacking the 120 residue amino terminal fragment were diluted and spotted 
onto YPD plates (at 30°C and 37°C), as well as on 4% and 6% ethanol as described 
above.
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fragment expressed from a 2µ plasmid (strain CY6161). The expression of Spt71-120 
(checked via Western Blot analysis; data not shown) in the context of the wild-type strain 
showed a minor decrease in growth on YPD and YPD containing 4% and 6% ethanol 
compared to the wild-type control alone, indicative of a dominant-negative phenotype 
(Figure 3.2b). 
!
3.3 N-terminal truncations of Spt7 reduce transcriptional activation at SAGA-
targeted promoters !
The growth defects seen as a result of the missing 73 and 121 amino terminal residues 
of Spt7 suggest a broad effect on SAGA function. I performed β-galactosidase assays to 
determine whether a lack of the N-terminal 73 or 121 amino acid residues of Spt7 would 
affect transcriptional activity at PHO5 and INO1. These genes were chosen based on the 
fact that their expression is SAGA-dependent. As illustrated in Figure 3.2, Spt773-1332 and 
Spt7121-1332 caused notable growth defects on both low phosphate medium and medium 
lacking inositol. To test for activity at the PHO5 promoter, cells were grown in YPD 
lacking phosphate; INO1 promoter activity was tested in inositol depleted conditions 
(Barbaric et al. 2003; Lo et al. 2005). As shown in Figure 3.3, the truncation mutants 
decreased transcript levels comparable to that of the spt7 knockout strain for both PHO5 
and INO1. Transcriptional activity was also tested at a promoter regulated by two SRE 
(stress responsive) elements. Similar to the results observed at PHO5 and INO1, a loss of 
expression of approximately 8% of wild-type was seen after growth in 6% ethanol. The 
magnitude of this effect was also comparable to that of the spt7 knockout.  
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Figure 3.3 Effect of N-terminal Spt7 truncations on transcriptional activation at 
PHO5, INO1, an SRE-containing promoter, and RPL35A. Strains carrying wild-type 
Spt7 on cen plasmid, along with Spt773-1332 and Spt7121-1332 mutants on 2µ plasmids and 
a spt7 knockout strain were tested for transcriptional activation. All LacZ fusions were 
expressed from a LEU2 centromeric plasmid. a) Strains carrying PHO5-LacZ were 
grown in YPD depleted of phosphate. b) Strains carrying INO1-LacZ were grown in 
medium lacking inositol. c) Strains carrying SRE/HIS3-LacZ were grown in 6% 
ethanol. d) Strains carrying RPL35A-LacZ were grown in YPD. β-galactosidase activity 
for each promoter was measured in triplicate and growth was for 16hrs.
a) b)
c) d)
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To determine whether this decrease in transcriptional activity was SAGA-specific, 
transcriptional activation was also tested at RPL35A, a ribosomal gene not targeted by 
SAGA (Huisinga and Pugh, 2004). A partial decrease in activation (~65% of wild-type 
levels) was seen with both Spt773-1332 and Spt7121-1332, an effect lesser than that at PHO5, 
INO1, and the SRE-containing promoter. The spt7 knockout strain showed the greatest loss 
in activity at RPL35A compared to either mutant, resulting in a decrease to 20% of wild-
type levels (Figure 3.3). 
!
3.4 N-terminal truncations of Spt7 partially decreases acetylation of H3K18 at PHO5 
in vivo !
The severe decrease in transcriptional activity seen with LacZ-PHO5, as well as the 
other promoters tested prompted me to ask whether Gcn5 driven acetylation at the PHO5 
promoter was also affected. Thus, I proceeded to examine the effect of the N-terminal 
truncations of Spt7 on histone H3 (K18) acetylation expressed as a ratio of total histone H3 
at the PHO5 promoter; the PGK promoter was also tested as a control. Figure 3.4a shows 
the mean percentages of acetylated lysine 18 (AcH3K18) to total histone H3 for strains 
CY5616 (Spt773-1332), CY4385 (Spt7121-1332), and FY1093 (spt7 knockout), all normalized 
to the AcH3K18/H3 ratio of wild-type carrying strain CY4367. Acetylation at the PHO5 
gene by Gcn5 requires inducing conditions, thus all strains were grown in YPD depleted of 
phosphate prior to the assay (Barbaric et al. 2003). As seen in Figure 3.4a, the ratio of 
AcH3K18 to total H3 was reduced to approximately 50% with the Spt773-1332 mutant and 
70% in context of Spt7121-1332. A decrease to 60% of wild-type levels was seen in the 
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3.4 Effect of N-terminal truncations of Spt7 on histone H3 acetylation at the PHO5 
and PGK promoters. a) Histone H3K18 acetylation at the PHO5 promoter. Yeast 
strains CY4367 (WT), CY5616 (Spt773-1332), CY4385 (Spt7121-1332), and FY1093 (spt7 
knockout) were grown to mid-log phase in YPD depleted of phosphate. ChIP was 
performed using anti-H3 and anti-H3K18 antibodies. Levels of acetylation at H3 and 
H3K18 were determined by PCR using primers flanking the PHO5 gene, and analysis 
of the products was done following gel electrophoresis on agarose gels stained with 
ethidium bromide. Serial dilutions in triplicate were performed to ensure a linear range. 
The results are shown as a percentage of the total H3 levels of the CY4367 (wild-type 
Spt7) strain, and are the average of two independent experiments. b) Histone H3K18 
acetylation at the PGK promoter. ChIP was performed the same way as with the PHO5 
promoter, except primers flanking the PGK gene were used; these results are based on a 
single experiment, with serial dilutions also done in triplicate. 
a) b)
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FY1093 (spt7 knockout) strain. Interestingly, the Spt773-1332 mutant resulted in the lowest 
acetylation levels, even when compared with the spt7 knockout. 
At the PGK promoter, the ratio of AcH3K18 to total H3 was 85% in CY5616 
(Spt773-1332) and 75% in CY4385 (Spt7121-1332) relative to the wild-type strain, showing a 
slightly lesser decrease in acetylation as compared to the PHO5 promoter. A decrease to 
40% of wild-type levels was seen in the FY1093 (spt7 knockout) strain, representing a 
lower ratio than was observed at PHO5 (Figure 3.4b). 
!
3.5 Effect of the N-terminal Spt7121-1332 truncation mutant on interaction with Tra1  !
 The Spt773-1332 and Spt7121-1332 mutants produced notable phenotypic effects (Figure 
3.2), decreased transcriptional activation at SAGA-targeted promoters (Figure 3.3), and 
slightly reduced histone H3 acetylation at the PHO5 gene (Figure 3.4). To determine 
whether these effects were due to compromised integrity of SAGA, I examined whether 
Spt7121-1332 would disrupt interaction with subunits of the complex. I tested for interaction 
with Tra1, which occupies a peripheral portion of the complex away from Spt7 (Wu et al. 
2004). Flag3-wild-type Tra1 was transformed into the spt7 knockout strain (CY5871) along 
with myc9-wild-type Spt7 on a centromeric plasmid (CY6132), and myc9-Spt7121-1332 on a 
2µ plasmid (CY6139). As controls, strains separately carrying flag3-wild-type Tra1 
(CY6110) and myc9-wild-type Spt7 (CY6108) on plasmids were engineered. Flag3-Tra1 
was pulled down (2.5mg of protein from all extracts) using anti-flag M2 magnetic beads 
followed by separation of eluted protein by SDS-PAGE and Western blot analysis. 
Membranes were probed using α-myc and anti-flag antibodies to detect for the presence of 
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3.5 Tra1-Spt7 immunoprecipitation. Yeast strains CY6132 (flag3-Tra1 on cen plasmid 
and myc9-wild-type Spt7 on cen plasmid in the spt7 knockout strain FY1093), CY6139 
(flag3-Tra1 on cen plasmid and myc9-Spt7121-1332 on 2µ plasmid) were grown up to mid-
log phase in YPD along with control strains CY6110 (flag3-Tra1 on cen plasmid in 
FY1093) and CY6108 (myc9-wild-type Spt7 on cen plasmid in FY1093). a) The top gel 
shows the membrane probed against myc9-Spt7. b) The bottom gel shows the membrane 
probed against flag3-Tra1. On both top and bottom gels, lanes 1-4 show input protein, and 
lanes 5-8 show IP elutions as indicated by the dividing line. Each lane is marked to 
indicate the presence or absence of each tagged protein as labelled.
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myc9-Spt7 and flag3-Tra1, respectively. Tra1 levels were slightly lower in the strain 
carrying wild-type Spt7 versus the strain carrying Spt7121-1332, as shown in lanes 1 versus 2 
of Figure 3.5b, respectively. It should also be noted that the level of wild-type Spt7 was 
higher compared to Spt7121-1332 in the input protein extracts (lanes 1 versus 2 Figure 3.5a, 
respectively). Analysis of the membrane probed for myc9-Spt7 showed that both wild-type 
(lane 5) and mutant Spt7 (lane 6) co-immunoprecipitated with Tra1 (Figure 3.5a); 
interestingly, a greater amount of Tra1 was present in the strain carrying the Spt7121-1332 
mutant (lane 6, Figure 3.5b). The results  presented here indicate that the N-terminal 
truncation of Spt7 does not have an effect on its association with Tra1. 
!
3.6 Investigating the effect of Spt7121-1332 on Spt7-Gcn5 interaction via gel filtration 
analysis    !
 Given that a lack of the N-terminal 121 residues had no effect on Spt7’s association 
with Tra1, I decided to test for interaction with a more proximal subunit within the SAGA 
complex, Gcn5. I had technical difficulties with immunoprecipitations, so I looked for co-
fractionation after Superose 6 gel filtration chromatography. CY6099 carried flag3-wild-
type Spt7 (cen) and myc9-Gcn5 (2µ), and CY6308 carried flag3-Spt7121-1332 (2µ) and myc7-
Gcn5 (2µ); the difference in tag length ensured that no confusion would arise between the 
strains. 2mg of protein extract from CY6099 and CY6308 were independently 
chromatographed on a Superose 6 HR10/30 size exclusion column. Every other fraction 
was separated by SDS-PAGE and the presence of myc-Gcn5 was analyzed by Western blot 
analysis. Note that the elution fractions from CY6099 (wild-type Spt7) and CY6308 
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3.6 Fractionation of Gcn5 from a Superose 6 size exclusion column from strains 
carrying either Spt7WT or Spt7121-1332. Yeast strains CY6099 (flag3-wild-type Spt7 on 
cen plasmid + myc9-Gcn5 on 2µ) and CY6308 (flag3-Spt7121-1332 on 2µ plasmid + myc7-
Gcn5 on 2µ) were grown to mid-log phase in YPD. 2mg of 6099 and 6308 lysed cell 
extract was separately applied over a Superose 6 HR10/30 size exclusion column and 
every other fraction was separated by SDS-PAGE followed by Western blot analysis. a) 
Spt7WT represents extracts from CY6099 (every numbered lane) while Spt7121-1332 
represents extracts from CY6038 (lanes lacking numbers), as indicated by the arrows. 
Membranes were probed with α-myc Ab to detect myc9-Gcn5 and b) anti-flag Ab to 
detect flag3-Spt7. Fractions #3-11, #13-21, #23-31, and #33-39 to be probed were 
loaded on separate gels due to well limit per gel, as illustrated by the black vertical lines 
separating each membrane. Note that fraction #33 is present at the end of the last gel 
due to an error in loading. 
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(Spt7121-1332) were loaded side-by-side for each fraction so that a more accurate comparison 
between Gcn5 levels could be made. Gcn5 signal was present in context of the Spt7121-1332 
carrying mutant strain in the same fractions (#27-39) as the wild-type carrying strain 
(Figure 3.6a). The strain containing Spt7121-1332 showed a greater expression compared to 
that carrying the wild-type due to the fact that the Spt7121-1332 mutant was expressed on a 2µ 
plasmid (Figure 3.6b). This result supports the view that Spt7121-1332 does not have an 
affect on the association of Gcn5 with Spt7. 
!
3.7 Localization of Spt773-1332 and Spt7121-1332 via fluorescence microscopy    
 Since Spt7121-1332 did not have an effect on its association with either Gcn5 or Tra1, 
perhaps the observed effects on expression, growth, transcriptional activation and 
acetylation could be due to a change in localization as a result of the missing N-terminal 
residues. To test this, yeast strains carrying N-terminally eGFP-tagged wild-type Spt7 
(CY6079), Spt773-1332 (CY5922) and Spt7121-1332 (CY5921) on 2µ plasmids were 
engineered. All eGFP-tagged proteins were expressed in a yeast strain containing 
endogenous Spt7 (BY4741) to prevent potential complications as related to growth defects 
seen with a spt7 knockout strain (Figure 3.2). When grown in YPD, wild-type Spt7 
localized exclusively to the nucleus. No obvious difference in cellular localization was seen 
with either the Spt773-1332 or Spt7121-1332 mutants. Both of the mutant strains showed a 
predominantly nuclear localization, although a decrease in relative signal intensity was seen 
compared to wild-type (Figure 3.7a). In addition, localization appeared to remain in the 
nucleus upon growth in YPD containing 6% ethanol (Figure 3.7b).  
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3.7 Localization of full-length Spt7WT, Spt773-1332, and Spt7121-1332. a) SC medium: 
Yeast strains CY6079 (eGFP-wild-type Spt7), CY5922 (eGFP-Spt773-1332), and CY5921 
(eGFP-Spt7121-1332) were grown to mid-log phase in medium lacking uracil to ensure 
plasmid maintenance, followed by DAPI staining. Excess DAPI was washed off with 
PBS, and cells were visualized by fluorescence microscopy. BF, bright field. Bar: 10µm 
(bottom right). Note that partial drying out of the slide occurred when analyzing the 
CY6079 strain. b) SC medium containing 6% ethanol. CY6079, CY5922 and CY5921 
were grown to mid-log phase in medium lacking uracil, followed by dilution and 
growth in SC medium containing 6% ethanol for another 16hrs. Cells were 
subsequently visualized by fluorescent microscopy. DAPI staining is ineffective in the 
presence of ethanol. c) Diploid yeast strain containing Spt71-120 fragment/wild-type-
Spt7 (CY6162) was grown in SC medium and stained with DAPI as described above, 
and visualized by fluorescence microscopy.
!52
 Although no change in localization was seen with respect to Spt773-1332 or 
Spt7121-1332, I tested whether a GFP-tagged 1-120 amino residue fragment alone would also 
exhibit nuclear localization. Thus, yeast strain carrying eGFP-Spt71-120 fragment in context 
of a second wild-type copy of Spt7 (CY6162) was engineered and observed via 
fluorescence microscopy. The results indicate a diffuse distribution of eGFP-Spt71-120 
throughout the cell that is not exclusive to the nucleus (Figure 3.7c).  
!
3.8 Lipid binding by the extreme N-terminus of Spt7 
 We identified a potentially novel lipid-binding motif at the extreme N-terminus of 
Spt7 (Figure 1.3b). As mentioned previously, Hoke et al. (2008a) found that Spt7 bound 
phosphatidylserine (PS) independent of Ada2, which also binds PS. To follow this up, I 
sought to map the region of lipid-binding by Spt7, directing my focus on the putative N-
terminal lipid binding domain. Plasmid constructs containing GST fusions of N-terminal 
1-439, 1-121 and 1-73 fragments were generated and purified using an E. coli expression 
system. These fragments were purified using a GST column, followed by spotting onto PIP-
strips: hydrophobic membranes spotted with 100pmol of phosphatidylinositols and other 
physiologically relevant lipids (Figure 3.8c). Two hundred micrograms of each protein was 
used and the PIP-strips were separately probed with anti-GST antibody. As shown in 
Figure 3.8a, all three N-terminal fragments showed lipid-binding to numerous PIPs, most 
notably PtdIns(3)P and PtdIns(3,5)P2. Signal variability was observed due to the variable 
nature of the assay.  
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3.8 Lipid binding by N-terminal fragments of Spt7. a) Wild-type N-terminal Spt7 
fragments. GST-tagged N-terminal fragments were purified using a GST-column and 
eluted with  25mM glutathione. 200µg of protein was added to PIP-strips, and probed 
with GST-antibody. b) 1-73 R4QK8QR12QK16Q mutant. Equal amounts (200µg) of 
wild-type 1-73 amino acid residue fragment and R4QK8QR12QK16Q mutant peptide 
were overlaid onto PIP-strips and probed with GST-antibody. c) PIP-strip schematic. 
Distribution of lipid species on PIP-strips used in lipid-overlay assay (Echelon 
Biosciences). d) Wild-type and R4QK8QR12QK16Q 1-73 Spt7 protein fragments were 
purified by GST-column using 0.5mM IPTG at 15°C. Purified protein was separated by 
SDS-PAGE and stained using Coomassie Brilliant Blue to ensure induction of protein 
expression prior to performing the lipid overlay assay.   
!54
 The observation that the first 73 amino terminal residues were sufficient for lipid 
binding raised the possibility that the alternating pattern of positively charged residues at 
the extreme N-terminus of Spt7 coordinated this lipid binding. Thus, I asked whether 
specific mutations in these positively-charged residues would cause defects in binding. To 
this end, site-directed PCR mutagenesis was performed to mutate the first four positive 
residues to glutamines. Interestingly, the 1-73 R4QK8QR12QK16Q mutant reproducibly 
showed complete loss of binding to all lipid species on the PIP-strips (Figure 3.8b). The 
purified proteins used in the PIP-strip assay are illustrated in Figure 3.8d. 
!
3.9 Changes in lipid binding specificity by Spt7 N-terminal mutant fragments  
 To further investigate the specificity of lipid binding of the first four positively-
charged residues, two additional mutant fragments were engineered via site-directed 
mutagenic PCR.  These mutants carried double mutations in the first two (Spt7-R4QK8Q), 
and third and fourth positively-charged residues in combination (Spt7-R12QK16Q). While 
the R12QK16Q mutant retained the ability to bind PtdIns(3)P and PtdIns(3,5)P2, the R4QK8Q 
mutant lost binding to both lipid species (Figure 3.9a). The purified proteins used in the 
PIP-strip assay are shown in Figure 3.9c. 
!
!
!
!
!
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3.9 Lipid binding by N-terminal mutant fragments of Spt7. a) Double mutants. 
GST-tagged 1-73 N-terminal residue fragments carrying double mutations, R4QK8Q 
and R12QK16Q, were purified using a GST-column and eluted with 25mM glutathione, 
along with the 1-73 residue wild-type fragment. 200µg of protein was added to PIP-
strips, and probed with GST-antibody to detect lipid-binding to various species. b) PIP-
strip schematic. Distribution of lipid species on PIP-strips used in lipid-overlay assay 
(Echelon Biosciences). c) Wild-type, R4QK8Q, and R12QK16Q 1-73 Spt7 protein 
fragments were purified by GST-column using 0.5mM IPTG at 15°C. Purified protein 
was separated by SDS-PAGE and stained using Coomassie Brilliant Blue to ensure 
induction of protein expression prior to performing the lipid overlay assay.
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3.10 Phenotypes of strains carrying N-terminal point mutations 
 The difference in lipid binding specificity observed by altering just two of the 
positively charged residues at the N-terminus of Spt7 allowed me to pinpoint the region 
necessary for binding PtdIns(3)P and PtdIns(3,5)P2. To test whether loss of this binding 
affected the growth of yeast, strains containing full-length Spt7 carrying the R4QK8Q 
(CY5798), R12QK16Q (CY5795), and R4QK8QR12QK16Q (CY5797) mutations on plasmids 
were engineered, along with a strain containing wild-type Spt7 (CY5796). Cultures were 
grown to stationary phase, serially diluted, and spotted onto YPD, medium lacking inositol 
and YPD containing 6% ethanol. The spt7 null strain (CY4465) showed the most severe 
growth defect. Although the mutants did not show nearly as severe an effect as that of the 
null strain, Spt7-R4QK8Q grew slower than either the R12QK16Q double-, or 
R4QK8QR12QK16Q quadruple mutants at 37ºC and on medium lacking inositol (Figure 
3.10). This was consistent with the loss of PtdIns(3)P and PtdIns(3,5)P2 lipid binding seen 
with Spt7-R4QK8Q as compared to the R12QK16Q mutant (Figure 3.9). However, the fact 
that the R4QK8QR12QK16Q quadruple mutant showed a lesser phenotype compared to Spt7-
R4QK8Q under these conditions presents an inconsistency with regards to the size of the 
mutation and effect on growth. On the other media tested (YPD at 30ºC, YPD containing 
6% ethanol), the three mutants showed a minor decrease in growth (Figure 3.10).  
!
!
!
!
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Figure 3.10 Phenotypes of N-terminal point mutations of full-length Spt7. Serial 
dilutions of yeast strains CY5796 (wild-type Spt7), CY5798 (full length Spt7 carrying 
R4QK8Q mutation), CY5795 (Spt7 carrying R12QK16Q mutation), CY5797 (Spt7 
carrying R4QK8QR12QK16Q mutation), and CY4465 (spt7 knockout) were spotted onto 
YPD plates at (30°C and 37°C), medium lacking inositol, and YPD containing 6% 
ethanol.
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3.11 Spt7 localization in the context of fab1 and vps34 deletion backgrounds 
I next asked whether the absence of PtdIns(3)P and PtdIns(3,5)P2 lipid species in yeast 
strains would affect Spt7 localization in the cell. A fab1 knockout strain containing eGFP-
tagged wild-type (CY6085), Spt773-1332 (CY6087) or Spt7121-1332 (CY6086) Spt7 was 
generated. Likewise, vps34 knockout strains carrying eGFP-tagged wild-type Spt7 
(CY6089), Spt773-1332 (CY6091) or Spt7121-1332 (CY6090) were engineered. Vps34 is the 
kinase responsible for converting PtdIns to PtdIns(3)P, which is subsequently 
phosphorylated by Fab1 to form PtdIns(3,5)P2 (Strahl and Thorner, 2007). As shown in 
Figure 3.11, both strains exhibited altered morphology, including greatly enlarged 
vacuoles. The eGFP-Spt7 signal showed nuclear as well as cytoplasmic localization in both 
knockout strains. Interestingly, the distribution of signal appeared more nuclear in the 
vps34Δ strain (Figure 3.11b) compared to the fab1Δ strain (Figure 3.11a). 
!
3.12 Localization of Tti2 and Tti2-F328S 
As part of our investigation into the function of the FATC domain of Tra1, we analyzed 
the suppression of the Tra1-F3744A mutant by Tti2-F328S. Apart from multiple 
biochemical assays performed by other members of our lab including ChIPs, β-
galactosidase assays, and Western blots (Genereaux et al. 2012), I performed fluorescence 
microscopy to investigate whether the Tra1 mutation altered the protein’s cellular 
localization, and in turn, whether a difference would be seen in context of the Tti2-F328S 
suppressor. 
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3.11 Localization of full-length Spt7WT, Spt773-1332, and Spt7121-1332 in the context of 
fab1 and vps34 knockout strains. a) Localization in Fab1Δ background. Yeast strains 
CY6085 (eGFP-wild-type Spt7), CY6087 (eGFP-Spt773-1332), and CY6086 (eGFP-
Spt7121-1332) were grown to mid-log phase in medium lacking uracil to promote plasmid 
maintenance, followed by DAPI staining. Following washing in PBS to get rid of 
excess DAPI, cells were visualized by fluorescence microscopy. BF, bright field. Bar: 
10µm (bottom right). b) Localization in Vps34Δ background. Yeast strains CY6089 
(eGFP-wild-type Spt7), CY6091 (eGFP-Spt773-1332), and CY6090 (eGFP-Spt7121-1332) 
were grown to mid-log phase in medium lacking uracil, stained with DAPI and 
visualized by fluorescence microscopy as stated above.
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Prior to tracking the localization of Tra1 however, I looked at the cellular distribution 
of eGFP-tagged wild-type Tti2 and Tti2-F328S, as this had not yet been performed; this 
would also provide us with more information to better analyze the nature of suppression of 
the Tra1-F3744A allele. Figure 3.12 shows fluorescence microscopy for separate BY4741 
strains carrying eGFP-wild-type-Tti2 (CY5854) and eGFP-Tti2-F328S (CY6062). After 
growth to mid-log phase in synthetic complete medium and staining by DAPI, cells were 
visualized under the microscope. Wild-type Tti2 was both nuclear and cytoplasmic. No 
apparent difference was observed with the Tti2-F328S mutant, except for a slight decrease 
in eGFP signal intensity (Figure 3.12a). Growth in synthetic complete medium containing 
6% ethanol resulted in largely unchanged localization, except for the appearance of 
numerous foci near the vacuolar membrane within context of both wild-type and Tti2-
F328S (Figure 3.12b). 
!
3.13 Localization of Tra1, and Tra1-F3744A in presence and absence of Tti2-F328S  
Yeast strains containing N-terminally eGFP-tagged Tra1 (CY6029) and Tra1-F3744A 
(CY6025) were engineered in the context of a heterozygous diploid strain carrying a wild-
type copy of Tra1 to avoid potential complications of slow growth due to the Tra1-F3744A 
allele (refer to Figure 1.5 for phenotypes of Tra1-F3744A). Note that these strains also 
carried two copies of wild-type Tti2. Wild-type Tra1 was almost exclusively nuclear when 
grown in synthetic complete medium. The Tra1-F3744A mutant localized to the nucleus, 
but also mislocalized to numerous foci in the cytoplasm (Figure 3.13a). When grown in 
synthetic complete medium containing 6% ethanol, eGFP-Tra1-F3744A showed a higher 
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Figure 3.12 Localization of Tti2 and Tti2-F328S. a) BY4741 strains containing  
eGFP-wild-type-Tti2 (CY5854) or eGFP-Tti2-F328S (CY6062) were grown to mid-log 
phase in synthetic complete medium, followed by DAPI staining. Cells were washed in 
PBS and visualized by fluorescence microscopy. b) Cells were grown to stationary 
phase in SC medium, washed and grown until mid-log phase for another 18 hours in SC 
medium containing 6% ethanol. After washing in PBS, cells were visualized by 
fluorescence microscopy. DAPI staining was ineffective when grown in presence of 
ethanol. Bar, 10µm (bottom right). BF, bright field. 
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degree of diffusion to the cytoplasmic foci (Figure 3.13b). To test for the effect of the Tti2-
F328S suppressor, another diploid strain carrying eGFP-Tra1-F3744A/wild-type-Tra1 and 
Tti2-F328S/wild-type-Tti2 (CY6063) was made. Interestingly, the levels of cytoplasmic 
eGFP-Tra1-F3744A signal decreased in synthetic complete medium upon introduction of 
the Tti2-F328S suppressor (Figure 3.13a). Likewise, the mislocalization was partially 
reversed in medium containing 6% ethanol (Figure 3.13b). I used imaging software to 
quantify the fluorescent intensity of eGFP-Tra1, eGFP-Tra1-F3744A and eGFP-Tra1-
F3744A/Tti2-F328S  per unit area in the nucleus as compared to the whole cell, taking an 
average of 20 cells per calculation. As Table 3.1 shows, the ratio of nuclear to cytoplasmic 
GFP signal in synthetic complete medium, as well as medium containing 6% ethanol, 
increased upon introduction of the Tti2-F328S suppressor mutant, confirming the visual 
effect described above. Note that because DAPI staining was ineffective in ethanol-
containing medium, I assumed that the area with the most concentrated GFP-signal 
represented the nucleus, alongside its shape and location within the cell. 
!
!
!
!
!
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Figure 3.13 Localization of Tra1 and Tra1-F3744A in the presence of Tti2 or Tti2-
F328S. a) Yeast strains containing eGFP-Tra1/Tra1 Tti2/Tti2 (CY6029), eGFP-Tra1-
F3744A/Tra1 Tti2/Tti2 (CY6025), and eGFP-Tra1-F3744A/Tra1 Tti2-F328S/Tti2 
(CY6063) were grown in synthetic complete medium to mid-log phase stained with 
DAPI and visualized by fluorescence microscopy. b) The two rightmost panels are 
strains grown in SC containing 6% ethanol. BF, bright field. Bar, 10µm (bottom right)
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Table 3.1: Relative concentrations (fluorescence intensity per unit area) of eGFP-Tra1 
(wild type or F3744A) in the nucleus vs. total cell !!!!!!!!
Concentrations represent the intensity of eGFP fluorescence per unit area in the nucleus 
divided by the eGFP fluorescence per unit area for the cell (including the nucleus). 
Numbers represent the average for 20 cells. As DAPI staining was ineffective for the 
ethanol-grown cells, the most intense focus was assigned as the nucleus.
[Nuclear eGFP-Tra1]/[total cell eGFP-Tra1]
Tra1/Tti2 (strain) SC medium SC plus 6% ethanol
WT/WT (CY6029) 4.0 ± 0.6 2.4 ± 0.5
F3744A/WT (CY6025) 2.7 ± 0.5 2.0 ± 0.4
F3744A/F328S (CY6063) 3.5 ± 0.4 2.5 ± 0.5
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3.14 Comparing localization of Tra1-F3744A with membrane constituents. 
In an effort to determine the nature of the foci in which Tra1-F3744A was found, 
diploid strains containing eGFP-Tra1-F3744A/wild-type-Tra1 and several RFP-tagged 
membrane constituents (kindly provided by Peter Arvidson) were generated. Localization 
of RFP-tagged Anp1 (Golgi apparatus), Sec13 (ER to Golgi vesicles), and Nic96 (nuclear 
periphery) was analyzed simultaneously with eGFP-Tra1-F3744A after growth in medium 
containing 6% ethanol (Figure 3.14a). All RFP-tagged constituents showed a general 
overlap with the eGFP-Tra1-F3744A signal, the most prominent of which was Anp1. I 
repeated this experiment in synthetic complete medium. As shown in Figure 3.14b, Tra1-
F3744A retained mostly nuclear localization (as well as localization to cytoplasmic foci) 
confirming the results described above. In addition, I analyzed co-localization with three 
more RFP-tagged constituents, Cop1 (Early Golgi), Snf7 (endosome), and Pex3 
(peroxisome). A general overlap was also seen (Figure 3.14c), rendering it difficult to 
pinpoint the exact type of membrane to which the Tra1-F3744A mutant localized. 
!
!
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Figure 3.14 Localization of eGFP-Tra1-F3744A with RFP-tagged membrane 
constituents. a) Localization of eGFP-Tra1-F3744A and RFP-tagged Anp1, Sec13, 
and Nic9 in SC medium containing 6% ethanol. Diploid strains containing a single 
copy of each tagged allele were grown to stationary phase in SC medium. Cells 
were then washed with PBS and grown to mid-log phase in SC containing 6% 
ethanol, followed by visualization using fluorescence microscopy. b) Localization 
of eGFP-Tra1-F3744A and RFP-tagged Anp1, Sec13, and Nic9 in SC medium. 
Columns 3 and 5 from the left represent merged images between eGFP (green) and 
RFP or eGFP and DAPI, respectively. Bar, 10µm (bottom right). c) Localization of 
eGFP-Tra1-F3744A and RFP-tagged Cop1, Snf7, and Pex3 in SC medium 
containing 6% ethanol. Cells were grown to stationary phase in SC medium, 
washed with PBS and diluted in SC medium containing 8% ethanol (to make up a 
total concentration of 6% ethanol), grown a further 18 hours, and visualized by 
fluorescence microscopy. Bar, 10µm (bottom right)
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Chapter 4: Discussion 
Spt7 
 The first 121 amino terminal residues of Spt7 are crucial for its full expression, for 
transcriptional activation of target promoters and their histone acetylation in inducing 
conditions. Deletion of this region leads to numerous growth phenotypes. In addition, I 
found that the 1-121 amino terminal region does not play a role in maintaining interaction 
with the SAGA subunits, Tra1 (Figure 3.5) and Gcn5 (Figure 3.6). Likewise, the lack of 
this N-terminal region did not cause mislocalization of Spt7 away from the nucleus, as 
confirmed by fluorescence microscopy (Figure 3.7).  
 The extreme N-terminus binds PtdInsPs. Complete loss of binding was seen when 
the first four positively charged residues of Spt7 were mutated to glutamines (Figure 3.8). 
Specific binding to PtdIns(3)P and PtdIns(3,5)P2 was lost upon mutating the first two of 
these residues (Spt-R4QK8Q), but remained unchanged in context of cells carrying the 
Spt7-R12QK16Q mutant (Figure 3.9). These results were consistent with a minor phenotypic 
effect seen with the Spt7-R4QK8Q mutant in medium lacking inositol and high temperature 
growth conditions (Figure 3.10). In strains lacking PtdIns(3)P and/or PtdIns(3,5)P2, 
changes in eGFP-Spt7 localization were observed, further suggesting that PtdIns binding by 
Spt7 may be important for its function. By studying the N-terminal region of yeast Spt7, I 
have potentially uncovered new ways in which the SAGA complex is regulated in S. 
cerevisiae. 
!
!
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4.1 The N-terminal 121 residues of Spt7 are necessary for its full expression 
 Our initial finding that the Spt7121-1332 mutant decreased expression levels of Spt7 
could be due to several factors. First, the lack of the N-terminal residues could result in 
decreased protein stability, as well as a potentially weaker association with the SAGA 
complex. This would likely render the truncation mutant more susceptible to proteolysis. 
The observation that Spt7121-1332 showed several bands below that of the indicated Spt7form3 
band which were absent from the wild-type sample lane further validates the possibility of 
increased levels of degradation, and thus targeting for proteolysis. In addition, expression 
of the truncation mutant on a multi-copy plasmid could possibly result in over-saturation of 
Spt7 in the nucleus, thus leading to degradation and re-cycling of excess Spt7 not utilized 
by the SAGA complex.   
 Because no difference was observed in the relative levels of Spt7SLIK and Spt7form3 
between wild-type and mutant protein, the 1-121 amino terminal region of Spt7 has no 
effect on processing of full-length Spt7 into its Spt7SLIK or Spt7form3 counterparts. This has 
previously been found by Hoke et al, who showed that the C-terminus is sufficient for 
processing of full-length Spt7 to its Spt7SLIK and Spt7form3 counterparts, and does not 
require the N-terminus of the protein up to the region of the histone fold motif (residues 
979-1045) (Hoke et al. 2007). 
!
4.2 The lack of the first 73 and 121 amino terminal residues severely affects growth 
and transcriptional activation at SAGA targeted promoters  !
 In a study by Wu and Winston (2002), a N-terminally truncated mutant of Spt7 was 
made which lacked the first 873 residues of the protein (spt7-100). A diploid strain carrying 
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two copies of this mutation (spt7-100/spt7-100) was tested for growth defects alongside a 
set of C-terminal truncations. This N-terminal truncation resulted in partially reduced 
growth on medium lacking inositol, and medium containing galactose. This defect in 
growth was nearly fully restored to that of wild-type levels through complementation by a 
second copy of Spt7 expressing the missing N-terminal residues (spt7-873). It is interesting 
to note that the spt7-873/spt7-873 diploids (which lacked the N-terminus) showed a similar 
lack in growth as the spt7-100/spt7-100 (lack of C-terminus). The biochemical effects of 
the N-terminal deletion were not pursued further however, as the paper was focused on 
specifics relating to the C-terminal portion of the protein (Wu and Winston, 2002).  
 Haploid strains carrying Spt773-1332 and Spt7121-1332 mutant proteins showed a more 
drastic decrease in growth compared to wild-type Spt7 than Wu and Winston’s strain 
carrying spt7-873 (lacking the C-terminus) under growth conditions such as medium 
lacking inositol. Such a drastic effect due to lack of the first 73 and 121 N-terminal residues 
suggests an important role of this region in Spt7 function. It is possible that the N-terminus 
may fold back to interact with and regulate a downstream region of the protein. In such a 
case, deletion of the first 121 residues would leave the adjacent portion of the protein 
unregulated and cause potential destabilization of Spt7. This self regulation could be 
similar to the PIKKs, where folding takes place to facilitate the interaction of the C-
terminal FATC domain with the PI3K region (Lempiäinen and Halazonetis 2009). 
 The greatest decrease in growth for the Spt773-1332 and Spt7121-1332 mutants was 
observed in medium lacking inositol; this agrees with the fact that SAGA directly plays a 
role in the transcriptional activation of INO1 (Marcus et al. 1996; Dietz et al. 2003; 
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Horiuchi et al. 2007). In the absence of cellular inositol, SAGA via its Gcn5 subunit 
acetylates lysine 14 of histone H3 after its recruitment to the promoter by Snf1 (Lo et al. 
2005). Likewise, SAGA controls the response of the cell to varying phosphate levels 
through transcriptional activation at PHO5 (Barbaric et al. 2003). The decreased growth 
under these conditions was consistent with the severe decrease in transcriptional activation 
at both PHO5 and INO1 (comparable in magnitude to that of an spt7 knockout). This 
decreased transcription could have been a direct result of either i) a lack of physical 
recruitment of SAGA to the promoter, ii) altered function at the promoter preventing the 
necessary acetylation by Gcn5 to take place or iii) a loss of interaction with specific 
activators at the promoter. Combining the transcription defects with the observed growth 
effects strongly suggests that the N-terminus of Spt7 plays a role in regulating SAGA-
driven activation at its target genes. This was also indirectly confirmed by testing for 
transcriptional activity at RPL35A, a component of the 60S large ribosomal subunit 
(Babiano and Cruz, 2010) whose transcription is regulated by the TFIID complex (Huisinga 
and Pugh, 2004). The milder effect on transcription seen as a result of the truncation 
mutants at this promoter shows that the effect of the N-terminal residues of Spt7 is SAGA-
specific. Given the breadth of phenotypes as a result of the N-terminal truncated mutants of 
Spt7, combined with the severe decrease in transcriptional activation at SAGA-targeted 
genes, I conclude that the extreme N-terminus of Spt7 affects the general ability of SAGA 
to effectively regulate its target genes.  
!
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4.3 The extreme N-terminal region of Spt7 is necessary for acetylation at lysine 18 of 
histone H3 at the PHO5 promoter !
 It is established that Gcn5 preferentially acetylates SAGA-targeted genes at histone 
H2B and H3 (Kuo et al. 1996; Grant et al. 1999). More specifically, acetylation at lysine 18 
(K18) of histone H3 is essential for activation of genes such as HXT2 and HXT4 (van 
Oevelen et al. 2005) as well as ARG1, CTT1, FUS1, and VTC1 (Hoke et al. 2008a). Testing 
for effects of N-terminal truncated mutants on K18 of histone H3 at the PHO5 promoter, I 
found acetylation to be down in strains carrying Spt773-1332 and Spt7121-1332 to ~50% and 
~70%, respectively. This drop in levels was comparable to that of a spt7 knockout strain 
(~60% of total H3 levels). In 1999, Eberharter et al showed that the ADA module, 
consisting of Ada2, Gcn5 and Ngg1/Ada3 is stable and active as its own complex in the 
cell. This partial drop in acetylation as a result of the missing 73 and 121 N-terminal 
residues of Spt7 suggests that acetylation was not completely inhibited due to retained 
Gnc5 activity in the context of the independent ADA module. In comparison with these 
results, Genereaux et al (2012) found that acetylation of H3K18 in an ada2 knockout strain 
was drastically reduced to levels near zero. This finding confirms the necessity of Ada2 in 
regulating Gcn5, as previously hypothesized (Barbaric et al. 2003), as well as confirming 
that unlike Ada2, the N-terminus of Spt7 does not regulate Gcn5 acetylation outside of its 
association with the SAGA complex.  
 The observed decrease in acetylation to approximately 80% of wild-type levels seen 
with both truncation mutants at the PGK1 promoter (40% of wild-type levels with the spt7 
knockout) may indicate indirect/off target effects as a result of not having fully functional 
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SAGA in the nucleus or a general role for SAGA in non-targeted histone acetylation. A 
recent study done in our lab showed a ~40% decrease with the Tra1-F3744A mutation at 
the PHO5 promoter (AcH4K8) compared to the wild-type ratio of acetylated/total histone 
H4, which is consistent with the ChiP results presented in this study (Genereaux et al. 
2012). In contrast, they found the level of acetylated K8 of H4 to be ~90% of wild-type 
levels at PGK1 as a result of the Tra1-F3744A mutation. This is comparable to the effect 
seen with my Spt7 mutants (80%). Interestingly, a publication by Downey et al (2013) 
showed that IFH1, a gene which controls ribosomal protein (RP) transcription is only 
acetylated by Gcn5 in the context of intact SAGA complex and requires Spt7 to be present. 
The N-terminus of Spt7 may regulate the Gcn5 subunit in such a way that it is required for 
full regulation at the PHO5 promoter and therefore suggests that most of the acetylation is 
mediated through SAGA rather than the ADA complex. 
!
4.4 The N-terminal truncation of Spt7 has no effect on its interaction with Tra1 and 
Gcn5 !
 A direct way for us to determine whether the effects described thus far were due to a 
loss of subunits from SAGA as a result of the missing 121 N-terminal residues was to 
perform immunoprecipitation assays. Previous studies by Wu et al (2004) and Lee et al 
(2011) mapped the numerous subunits of SAGA to specific modules. Tra1 was located 
away from Spt7 as part of its own module within the complex. Hoke et al (2010) found that 
an addition of a glycine at the C-terminus of Tra1 decreased association with Spt7, hinting 
at a structural connection between the two subunits in the context of SAGA. However, the 
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Tra1-L3733A mutant had no effect on interaction. My results suggest that a lack of the first 
121 amino-terminal residues of Spt7 does not affect the presence of Tra1 within SAGA.  
 The ADA module, which contains Gcn5, is found directly adjacent to where Spt7 
has been mapped (Wu et al. 2004). Thus, I predicted that a loss of interaction, or 
dissociation of Gcn5 from SAGA, would be more probable due to its close proximity to 
Spt7. In addition, a decrease in transcription (Figure 3.3) and acetylation (Figure 3.4) at 
SAGA-targeted promoters might coincide with dissociation of the ADA module from 
SAGA. The presence of Gcn5 in the context of the strain carrying Spt7121-1332 indicates that 
the mutation has no effect on Gcn5’s association with SAGA. In addition, combining this 
result with the fact that Tra1 association is not affected suggests that the extreme N-
terminus (up to residue 121) does not play a role in the maintenance of structural integrity 
of SAGA, although the effect on other SAGA subunits cannot be dismissed.  
 Overall, the severe decrease in growth and transcriptional levels, as well as lowered 
acetylation at lysine 18 of histone H3 at PHO5 are not due to a dissociation of Gcn5 from 
SAGA. Rather, it is likely that the N-terminus of Spt7 regulates Gcn5 in a more subtle 
fashion, perhaps by partially coordinating the recruitment of SAGA to target promoters. 
Another possibility could be that since the bromodomain of Gcn5 confers specificity of 
binding to targeted genes via H3 and H4 amino terminal peptides (Synthichaki et al. 2000), 
the N-terminus of Spt7 may help coordinate Gcn5’s binding to histones and facilitate 
transcriptional activation. 
!
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4.5 Spt7 localization is unaltered in the context of N-terminal truncations 
 The fact that eGFP-Spt773-1332 and eGFP-Spt7121-1332 mutants were prevalent in the 
nucleus under regular growth conditions, as well as in the presence of 6% ethanol leads to 
the conclusion that the defects caused by the lack of the extreme N-terminus of Spt7 were 
not due to a mislocalization of the protein. This does not dismiss the possibility that the 
mutants may have caused a mislocalization within the nucleus itself. Such an effect could 
not be detected due to limitations in resolution with fluorescence microscopy. It was 
interesting to find that the eGFP-Spt71-120 N-terminal fragment only partially localized to 
the nucleus, with the rest of the signal being found in the cytoplasm. This result is 
somewhat inconsistent with the dominant negative growth phenotype observed in Figure 
3.2b as a result of the expression of the Spt71-120 fragment, since I would predict it to be 
more prominently found in the nucleus if it is to affect SAGA function. However, perhaps it 
is possible that the small amount of the Spt71-120 fragment which localized to the nucleus 
could interfere with regular SAGA function. Another explanation for this effect on growth 
could be that the Spt71-120 fragment interfered with an aspect of formation of the SAGA 
complex within the cytoplasm. Expressing this fragment could potentially result in its 
binding and thus sequestering of SAGA subunits away from the complex, although this is 
unlikely given the previous observation that Spt7121-1332 did not affect Tra1 or Gcn5 
interaction. The possibility of Spt71-120 binding to another subunit of SAGA cannot be 
dismissed however. Also, binding of the fragment to PtdInsPs could prevent binding by 
SAGA, and thus affect proper functioning of the complex.  
!
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4.6 Lipid binding by Spt7 is important for its function 
 Our discovery of a potential novel lipid binding domain of Spt7 sparked interest in 
studying the role of lipid binding in the functioning of SAGA. In fact, Ada2 was previously 
found to bind phosphatidylserine, although the biochemical consequences of this binding 
are unknown (Hoke et al. 2008a). Every fourth residue of the first 28 residues of Spt7 is 
either a lysine or arginine (Figure 1.3b). A minimum number of two basic amino acids, 
including at least one aromatic residue is a general feature of lipid binding domains, as 
mentioned in a review by Rosenhouse-Dantsker and Logothetis (2007). However, from 
multiple in silico analyses, the potential lipid binding domain of Spt7 did not match any 
known lipid binding domains (Chris Brandl, personal communication). In addition, analysis 
of the first 120 N-terminal residues of Spt7 via raptor x structure prediction software 
showed that this region was unstructured. It should also be noted that previous unpublished 
data in our lab showed that the downstream portion of Spt7 (fragment encompassing 
residues 558 to 869) also bound PtdInsPs. This indicates that lipid binding by Spt7 is not 
exclusive to its extreme N-terminal portion. 
 The 1-73 residue wild-type Spt7 peptide bound to several species of PtdInsPs, 
including PtdIns(3)P and PtdIns(3,5)P2 which are relevant lipid species in yeast. PtdIns(3)P 
is mostly found at the endosomal membranes and in multivesicular bodies, while 
PtdIns(3,5)P2 is found on vacuolar membranes (Strahl and Thorner, 2007). However, since 
Spt7/SAGA acts in the nucleus, it is important to focus our analysis of this binding on its 
connection to nuclear processes affected by PtdInsPs. PtdInsPs have been found to affect 
regulation of proteins within the nucleus such that binding by transcription factors 
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facilitates transcriptional activation of specific genes. One example can be found in a study 
by Han and Emr (2011), where they showed PtdIns(3,5)P2 binding by a triad of interacting 
proteins Cyc8, Cti6 and the GTF Tup1 on late endosomal membranes. This binding results 
in a switch from a Tup1 corepressor state (Cyc8-Tup1) to a coactivator state (Cti6-Cyc8-
Tup1 complex), facilitating its import back into the nucleus to recruit SAGA to the GAL1 
promoter, leading to transcriptional activation (Han and Emr, 2011). As suggested by Han 
and Emr (2011), tight spatial and temporal control of specific signalling events within a 
highly complex intracellular environment would benefit from the coordinated binding of 
proteins with rare PIP species.   
 The observation that all lipid binding activity was lost upon mutation of the first 
four positively charged residues to glutamines highlights the importance of these residues 
to lipid binding. More specifically, it was interesting to see that mutation of the first two 
basic residues (R4QK8Q) led to a loss of binding to both PtdIns(3)P and PtdIns(3,5)P2, 
while mutation of the third and fourth residues in combination (R12QK16Q) showed 
unaltered binding. Although results based on the lipid-overlay assay are variable in nature 
(Yu et al. 2004), each overlay assay was repeated to ensure a general consistency in 
experimental outcome. The fact that the R4QK8Q mutant showed a greater phenotype on 
medium lacking inositol and YPD at 37ºC compared with both R12QK16Q, and 
R4QK8QR12QK16Q mutants was unexpected, since it would be predicted that the allele 
carrying four mutated residues would confer a more notable growth defect compared with 
one carrying only two mutations. This is likely explained by the fact that no binding to lipid 
is more acceptable to the cell than partial binding, since strict binding specificity is likely 
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required by Spt7 to properly aid SAGA in carrying out its regulatory functions. Brickner 
and Walter (2004) found that transcription of INO1 occurs at the nuclear periphery. Since 
PtdInsPs are usually found at membranes (Strahl and Thorner, 2007), PtdIns(3)P and/or 
PtdIns(3,5)P2 may aid in recruitment of SAGA via the N-terminus of Spt7 to coordinate 
INO1 activation under inducing conditions. If this binding is affected by partial specificity 
as a result of N-terminal mutations of Spt7, the necessary cues would likely be missing to 
support full regulation of SAGA by Spt7. The results presented in this study not only 
narrow down the region necessary for PtdInsP binding within the N-terminus of Spt7, but 
also show that a loss of binding to PtdIns(3)P and PtdIns(3,5)P2 may cause a minor 
decrease in cellular growth through affecting a specific aspect(s) of Spt7 function. Another 
way to test whether this lipid binding by Spt7 directly affects cell growth would be to 
utilize a lipid binding domain of another protein known to bind PtdIns(3)P and 
PtdIns(3,5)P2, such as the FRRGT domain of Atg18 (Krick et al. 2006). The FRRGT 
domain of Atg18 could be cloned in to replace the missing 73 N-terminal residues of Spt7, 
and PIP-strip assays as well as growth assays could be performed to test for a gain of 
binding to PtdIns(3)P and PtdIns(3,5)P2, as well as recovery from the minor growth defects 
observed, respectively. It would also be interesting to generate Spt7 mutants harbouring 
single mutations, such as Spt7-R4Q alone in an attempt to map the specific residues 
responsible for binding PtdIns(3)P and PtdIns(3,5)P2.   
!
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4.7 eGFP-tagged Spt7 mislocalizes in fab1 and vps34 deletion strains 
 Since Spt7 binds PtdInsPs, a change in the lipid balance of the cell might affect its 
function. Thus, I asked whether cells lacking both PtdIns(3)P and PtdIns(3,5)P2, or 
PtdIns(3,5)P2 alone would alter Spt7 localization. Interestingly, while both Fab1Δ [lacking 
PtdIns(3,5)P2] and Vps34Δ [lacking both PtdIns(3)P and PtdIns(3,5)P2] strains caused a 
mislocalization with both mutants and wild-type, the eGFP signal was slightly more 
dispersed in the context of the Fab1Δ strain compared to the Vps34Δ strain. The Vps34Δ 
strain showed the majority of eGFP to be in the nucleus. This result was intriguing, as it 
suggests that localization of Spt7 is more affected in a strain lacking only the PtdIns(3,5)P2 
lipid species. This brings about the possibility that a lack of binding due to absence of both 
lipid species results in Spt7 being shuttled back to the nucleus by chance, since it is not 
being held back in the cytoplasm by either lipid alone. In contrast, the Fab1Δ strain still 
contains PtdIns(3)P, which may result in sequestering of Spt7 on the endosomal membrane. 
Without PtdIns(3,5)P2, the necessary cue may be lacking to facilitate import of the protein 
into the nucleus. It should be noted that both fab1 and vps34 deletions cause transcriptional 
defects at SAGA-targeted promoters. Previous research in our lab showed a decrease in 
transcriptional activation at both PHO5 and INO1 to approximately 50% and 10% of wild-
type levels in Fab1Δ and Vps34Δ strains, respectively (Chris Brandl, unpublished). Such a 
finding provides a further link (direct or indirect) between PtdInsP regulation and SAGA 
function. 
!
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Tra1 
 Apart from investigating the functions of the N-terminus of Spt7, I contributed to 
furthering our understanding of how the FATC domain of Tra1 regulates this 3744 residue 
subunit of SAGA. Both wild-type Tti2 and the Tti2-F328S suppressor mutant showed 
nuclear as well as dispersed cytoplasmic eGFP signal. While wild-type Tra1 was 
exclusively nuclear, the Tra1-F3744A mutant partially mislocalized to cytoplasmic foci, 
especially when cells were grown in SC medium containing 6% ethanol. This 
mislocalization was partially reversed in a strain also carrying the Tti2-F328S suppressor. 
Lastly, the exact nature of the foci to which the FATC mutant of Tra1 mislocalized could 
not be specified, as its signal overlapped in a general fashion with numerous membrane 
components, including Anp1, Sec13, and Nic96. These results are briefly discussed below, 
drawing from the rest of our publication (Genereaux et al. 2012) and other research to 
discuss possible models in which the FATC domain regulates Tra1 via analysis of 
suppression by the Tti2-F328S allele. 
!
 4.8 Suppression of Tra1-F3744A by Tti2-F328S is partially achieved via an effect on 
its localization !
 Mislocalization of eGFP-Tra1-F3744A to cytoplasmic foci was observed compared 
to wild-type eGFP-Tra1. In our publication, we proposed that these foci are spots on 
membranes where Tra1 gets tethered as a result of the F3744A mutation (Genereaux et al. 
2012). This observation leads to a presumption that wild-type Tra1 also likely binds to 
membrane components, potentially to stabilize and/or facilitate its folding, or assembly of 
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complexes it has been found to be a part of. Since wild-type Tra1 shows nuclear 
localization, this binding is likely too temporary to be detected. In contrast, the F3744A 
mutant may render the binding to membranes more permanent, hence our ability to detect 
the cytoplasmic presence of the protein. The pattern of Tra1-F3744A localization to 
cytoplasmic foci seems to lack specificity to any particular membrane, since eGFP-Tra1-
F3744A signal did not exclusively overlap with any of the RFP-tagged membrane 
constituents alone. Rather, a general overlap was observed with RFP-tagged Anp1 (Golgi 
apparatus), Sec13 (ER-to-Golgi vesicles), Nic96 (nuclear periphery), Cop1 (retrograde 
vesicles), Pex3 (peroxisome), and Snf7 (late endosome to vacuole transport). 
 It was clear from my results that the Tti2-F328S suppressor reversed the 
mislocalization of Tra1-F3744A. Based on this, and other results in our paper (Genereaux 
et al. 2012), we concluded that Tti2 likely aids in the folding of Tra1. It is possible that 
decreased stability/folding efficiency experienced as a result of the Tra1 F3744A mutation 
may force the protein to stay on membranes for a longer period of time in order to fix this 
defect. The presence of Tti2-F328S likely results in accelerated folding of Tra1, facilitating 
its import into the nucleus to carry out its functions. 
!
4.9 Model and Conclusions 
 This study demonstrates that the extreme N-terminus of Spt7 plays an important 
role(s) in the function of SAGA through regulating transcriptional activation and 
acetylation at SAGA targeted promoters, as well as binding to phosphatidylinositol 
phosphates. The exact mechanisms by which the N-terminus regulates these processes 
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cannot be pinpointed based on this study alone. However, it is likely, as suggested by 
Gansheroff et al (1995), that Spt7 plays a role in coordinating transcription at the level of 
initiation, besides also being required for structural integrity of SAGA (Wu and Winston, 
2002). I ruled out the possibility of these effects being caused by a loss of interaction with 
Tra1 and Gcn5, since the missing N-terminal residues did not alter Spt7/SAGA’s 
association with these two subunits. To find out if the same applies for other subunits of 
SAGA, additional immunoprecipitation or gel filtration assays would need to be performed. 
Localization of Spt773-1332 and Spt7121-1332 was unchanged in comparison to wild-type 
protein, leading to the conclusion that the lack of the extreme N-terminal residues did not 
cause a mislocalization of Spt7 away from the nucleus. Mislocalization within the nucleus 
itself should not be ruled out however, especially the possibility of the truncation mutants 
affecting Spt7 function whereby the N-terminus is required for proper recruitment of SAGA 
to its target promoters, or sites of transcriptional initiation at the nuclear membrane.  
 I mapped the region required for PtdIns(3)P and PtdIns(3,5)P2 binding by the N-
terminus of Spt7 to the first two positively charged N-terminal residues R4 and K8. The 
fact that mutation at these two residues to glutamines caused a minor phenotype when 
grown in medium lacking inositol suggests that lipid binding by Spt7 plays a role in 
SAGA-driven transcriptional regulation by potentially targeting/anchoring Spt7, and thus 
SAGA, to specific sites within the nuclear membrane. The presence of PtdIns(3)P in the 
nuclear membrane (as well as nuclear speckles) presents a plausible scenario for the direct 
regulation of SAGA by PtdInsPs, as it has been established that the nuclear envelope is 
important for structural organization and spatial arrangement of proteins and protein 
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complexes which coordinate transcription (Schink et al. 2013; Steglich et al. 2013). 
Although PtdIns(3,5)P2 has not yet been found in the nucleus, it is indirectly important in 
facilitating cellular processes in which SAGA is involved (Han and Emr, 2011). Lastly, 
Ada2 has already been found to bind phosphatidylserine (Hoke et al. 2008a), making the 
notion of SAGA regulation by lipid binding that much more attractive.    
 The exact function of the FATC domain of Tra1 has yet to be established, although 
it likely folds back to interact with the PI3K domain, as has been demonstrated by Yang et 
al (2013) in the context of mTOR. It would be interesting to test for lipid binding by the 
FATC domain, since the Tra1-F3744A mutant was found to mislocalize to numerous foci 
within the cytoplasm, and since the nature of this binding to membrane components is not 
known. The association of Tra1 with membrane components makes lipid binding an 
attractive possibility, given the sensitivity that lipids and membranes exhibit in response to 
the environmental state. However, because the PI3K region does not bind lipid and since 
Tra1 does not contain any other regions likely involved in such binding, the direct binding 
of lipid by Tra1 is unlikely (Chris Brandl, unpublished). Alternatively, localization of Tra1 
to membrane components may be a direct consequence of Spt7’s affinity for lipid. 
Temporary docking to membranes via binding of Spt7 to lipids could serve as a structural 
docking site for the assembly of complexes within which Tra1 is found. Also, there lies the 
possibility that wild-type Tra1, which showed an exclusively nuclear signal could be 
specifically targeted within the nucleus by Spt7 to aid in the coordination of Tra1-
containing complexes to sites of transcriptional regulation. It would be interesting to 
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explore this connection by tracking the localization of Tra1-F3744A in the context of 
strains carrying N-terminal truncation mutants of Spt7. 
 I showed that the Tti2-F328S suppressor partially reversed mislocalization of Tra1-
F3744A from cytoplasmic foci. Separate assays performed in our lab suggest that this 
suppression effect is not due to increased interaction between the two proteins, or increased 
expression of the suppressor (Genereaux et al. 2012). Thus, we propose that Tti2 likely acts 
to aid in the folding of Tra1 via stabilization of the FATC domain. The effect of the Tra1-
F3744A mutant on transcriptional activation at the PHO5 promoter has also been tested, 
showing decreased levels to approximately one third of wild-type (Kvas, 2012). Acetylation 
at histone H3 of PHO5 yielded very little effect with the same mutant (Genereaux et al. 
2012). As seen with Spt7121-1332, the lack of a severe effect on acetylation is likely attributed 
to Gcn5 acting in the context of the ADA complex. The general resemblance in effects seen 
with both Tra1-F3744A and N-terminal Spt7 truncation mutants suggests a partial overlap 
in their requirement for facilitating SAGA-specific transcriptional activation. 
 Overall, the work presented in this thesis offers new perspectives on yeast Spt7, 
shedding light on previously unfound roles of its largely unstudied N-terminus. In addition, 
the discovery of lipid binding by the N-terminal region could prove to facilitate future 
research efforts into uncovering the subtleties of phosphatidylinositol phosphate binding on 
transcriptional regulation.  
!
!
!
!85
References 
Abraham, R. T. 2004. PI 3-kinase related kinases: ‘big’ players in stress-induced signalling 
pathways. DNA Repair (Amst). 3(8-9):883-7. !
Allard, S., Utley, R. T., Savard, J., Clarke. A., Grant. P., Brandl. C. J., Pillus. L., Workman, 
J. L.,  and Côté, J. 1999. NuA4, an essential transcription adaptor/histone H4 
acetyltransferase  complex containing Esa1p and the ATM-related cofactor Tra1p. 
EMBO J. 18:5108-19. !
Audhya, A., and Emr, S. D. 2002. Stt4 PI 4-kinase localizes to the plasma membrane and 
functions in the Pkc1-mediated MAP kinase cascade. Dev Cell. 2(5):593-605. !
Audhya, A., Foti, M., and Emr, S. D. 2000. Distinct roles for the yeast phosphatidylinositol  
 4-kinases, Stt4p and Pik1p, in secretion, cell growth, and organelle membrane 
dynamics,  Mol Biol Cell. 11:2673-89. !
Babiano, R., and de la Cruz, J. 2010. Ribosomal protein L35 is required for 27SB pre-
rRNA processing in Saccharomyces cerevisiae. Nucleic Acid Res. 38(15):5177-92. !
Balasubramanian, R., Pray-Grant, M. G., Selleck, W., Grant, P. A., and Tan, S. 2002. Role 
of the Ada2 and Ada3 Transcriptional Coactivators in Histone Acetylation. J Biol 
Chem. 277(10):7989-95. !
Barbaric, S., Reinke, H., and Horz, W. 2003. Multiple mechanistically distinct functions of 
SAGA at the PHO5 Promoter. Mol and Cell Biol. 23(10):3468-76. !
Belotserkovskaya, R., Sterner, D.E., Deng, M., Sayre, M. H., Lieberman, P. M., and S. L. 
Berger. 2000. Inhibition of TATA-binding protein function by SAGA subunits Spt3 
and Spt8 at Gcn4-activated promoters. Mol Cell Biol. 20:634-47. !
Berger, S. L., Pina, B., Silverman, N., Marcus, G. A., Agapite, J., Regier, J. L., Triezenberg, 
S. J., and Guarente, L. 1992. Genetic Isolation of ADA2: A Potential Transcriptional 
Adaptor Required for Function of Certain Acidic Activation Domains. Cell. 
70:251-65. !
Bhaumik, S. R., Raha, T., Aiello, D.P., and Green, M. R. 2004. In vivo target of a 
transcriptional activator revealed by fluorescence resonance energy transfer. Genes 
Dev. 18:333-343. !
Boeger, H., Griesenbeck J., Strattan, J. S., and Kornberg, R. D. 2004. Removal of promoter 
nucleosomes by disassembly rather than sliding in vivo. Mol Cell. 14(5):667-37. !
!86
Boronenkov, V., Loijens, J. C., Umeda, M. and Anderson, R. A. 1998. Phosphoinositide  
signalling pathways in nuclei are associated with nuclear speckles containing pre-
mRNA processing factors. Mol Biol Cell. 9:3547-60. !
Brandl, C. J., Furlanetto, A. M., Martens, J. A., and Hamilton, K. S. 1993. Characterization 
of NGG1, a novel yeast gene required for glucose repression of GAL4p-regulated 
transcription. EMBO J. 12(13):5255-65. !
Brickner, J. H., and Walter, P. 2004. Gene recruitment of the activated INO1 locus to the 
nuclear membrane. PLoS Biol. 2(11):e342. !
Brown, C. E., Howe, L., Sousa, K., Alley, S. C., Carrozza, M. J., Tan, S., and Workman, J. 
L. 2001. Recruitment of HAT complexes by direct activator interactions with the 
ATM-related Tra1 subunit. Science. 292:2333-37. !
Brownell, J.E., and Allis, C. D. 1995. An activity gel assay detects a single, catalytically 
active histone acetyltransferase subunit in Tetrahymena macronuclei. Proc. Natl. 
Acad. Sci. 92:6364-68. !
Brownell, J. E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D. G., Roth, S.Y., and 
Allis, C. D. 1996. Tetrahymena histone acetyltransferase A: a homolog to yeast 
Gcn5p linking histone acetylation to gene activation. Cell. 84:843-51. !
Buratowski, S., Hahn, S., Guarente, L.. and Sharp, P. A. 1989. Five Intermediate 
Complexes in Transcription Initiation by RNA Polymerase II. Cell. 56:549-61 !
Cocco, L., Martelli, A. M., Barnebei, O., and Manzoli, F. A. 2001. Nuclear inositol lipid  
signalling. Adv Enzyme Regul. 41:361-84. !
Cooke, F. T., Dove, S. K., McEwen, R. K., Painter, G., Holmes, A. B., Hall, M. N., Michell, 
R. H., and Parker, P. J. 1998. The stress-activated phosphatidylinositol 3-phosphate 5-
kinase Fab1p is essential for vacuole function in S. cerevisiae. Curr Biol. 8:1219-22 !
Daniel, J. A., and Grant, P. A. 2007. Multi-tasking on chromatin with the SAGA coactivator 
complexes. Mutat. Res. 618(1-2):135-48. !
Daniel, J. A., Torok, M. S., Sun, Z. W., Schieltz, D., Allis, C. D., Yates, J. R. 3rd., and 
Grant, P. A. 2004. Deubiquitination of histone H2B by a yeast acetyltransferase 
complex regulates transcription. J Biol Chem. 279:1867-71. !
DaSilva, L. F., Pillon, S., Genereaux, J., Davey, M. J., Gloor, G. B., Karagiannis, J., and 
Brandl, C. J. 2013. The C-terminal residues of Saccharomyces cerevisiae Mec1 are 
required for its localization, stability, and function. G3 (Bethesda). 3(10):1661-74. 
!87
Dietz, M., Heyken, W-T., Hoppen, J., Geburtig, S., and Schuller, H-J. 2003. TFIIB and 
subunits of the SAGA complex are involved in transcriptional activation of 
phospholipid biosynthetic genes by the regulatory protein Ino2 in the yeast. Mol 
Microbiol. 48(4):1119-30. !
Dove, S. K., Cooke, F. T., Douglas, M. R., Sayers, L. G., Parker, P. J., and Michell, R. H. 
1997. Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis. 
Nature. 390:187-92. !
Downey, M., Knight, B., Vashisht, A. A., Seller, C. A., Wohlschlegel, J. A., Shore, D. and  
Toczyski, D. P. 2013. Gcn5 and sirtuins regulate acetylation of the ribosomal protein 
transcription factor Ifh1. Curr Biol. 23(17):1638-48. !
Eberharter, A., Sterner, D. E., Schieltz, D., Hassan, A., Yates, J. R., Berger, S. L., and 
Workman J. L. 1999. The ADA complex is a distinct histone acetyltransferase 
complex in Saccharomyces cerevisiae. Mol Cell Biol. 19:6621-31. !
Fazzio, T. G., and Tsukiyama, T. 2003. Chromatin remodeling in vivo: evidence for a 
nucleosome sliding mechanism. Mol Cell. 12(5):1333-40. !
Ford, J., Odeyale, O., and Shen, C. H. 2008. Activator-dependent recruitment of SWI/SNF 
and INO80 during INO1 activation. Biochem Biophys Res Commun. 373(4):602-6. !
Gangloff, Y. G., Sanders, S. L., Romier, C., Kirschner, D., Weil, P. A., Tora, L., and 
Davidson, I. 2001. Histone folds mediate selective heterodimerization of yeast 
TAF(II)25 with TFIID components yTAF(II)47 and yTAF(II)65 and with SAGA 
component ySPT7. Mol Cell Biol. 21:1841-53. !
Gansheroff, L. J., Dollard, C., Tan, P., and Winston, F. 1995. The Saccharomyces cerevisiae 
SPT7 gene encodes a very acidic protein important for transcription in vivo. Genetics. 
139(2):523-36. !
Genereaux, J., Kvas, S., Dobransky, D., Karagiannis, J., Gloor, G. B., and Brandl, C. J. 
2012. Genetic evidence links the ASTRA protein chaperone component Tti2 to the 
SAGA transcription factor Tra1. Genetics. 191(3):765-80. !
Gozani, O., Karuman, P., Jones, D. R., Ivanoc, D., Cha, J., Lugovskoy, A. A., Baird, C. L., 
Zhu, H., Field, S. J., Lessnick, S. L., Villasenor, J., Mehrotra, B., Chen, J., Rao, V. R., 
Brugge, J. S., Ferguson, C. G., Payrastre, B., Myszka, D. G., Cantely, L. C., Wagner, 
G., Divecha, N., Prestwich, G. D., and Yuan, J. 2003. The PHD findger of the 
chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. 
Cell. 114:99-111. 
!88
Grant, P. A., Duggan, L., Cote, J., Roberts, S. M., Brownell, J. E., Candau, R., Ohba, R.,  
Owen-Hughes, T., Allis, C. D., Winston, F., Berger, S. L., and Workman, J. L. 1997. 
Yeast Gnc5 functions in two multisubunit complexes to acetylate nucleosomal 
histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. 
Genes Dev. 11(13):1640-50. !
Grant, P. A., Everharter, A., John, S., Cook, R. G., Turner, B. M., and Workman, J. L. 1999. 
Expanded lysine acetylation specificity of Gcn5 in native complexes. J Biol Chem. 
274:5895-5900. !
Hahn, S., and Young, E. T. 2011. Transcriptional regulation in Saccharomyces cerevisiae: 
transcription factor regulation and function, mechanisms of initiation, and roles of 
activators and coactivators. Genetics. 189(3):705-36. !
Han, B-K., and Emr, S. D. 2011. Phosphoinositide [PI(3,5)P2] lipid-dependent regulation of 
the general trancriptional regulator Tup1. Genes Dev. 25(9):984-95. !
Han, G. S., Audhya, A., Markely, D. J., Emr, S. D., and Carman, G. M. 2001. The   
Saccharomyces cerevisiae LSB6 gene encodes phosphatidylinositol 4-kinase activity. 
J Biol Chem. 277(49):47709-18. !
Hebbes, T. R., Thorne, A. W., and Crane-Robinson, C. 1988. A direct link between core 
histone acetylation and transcriptionally active chromatin. EMBO J. 7:1395-1402. !
Helmlinger D1, Marguerat S, Villén J, Swaney DL, Gygi SP, Bähler J, Winston F. 2011. 
Tra1 has specific regulatory roles, rather than global functions, within the SAGA 
coactivator complex. EMBO J. 30(14):2843-52. !
Henry KW, Wyce A, Lo WS, Duggan LJ, Emre NC, Kao CF, Pillus L, Shilatifard A, Osley 
MA, Berger SL. 2003. Transcriptional activation via sequential histone H2B 
ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8. Genes 
Dev. 17:2648-63. !
Hoke, S. M., Liang, G., Mutiu, A. I., Genereaux, J., and Brandl, C. J. 2007. C-terminal  
processing of yeast Spt7 occurs in the absence of functional SAGA complex. BMC 
Biochem. 8:16. !
Hoke, S. M., Genereaux, J., Liang, G., and Brandl, C. J. 2008a. A conserved central region 
of yeast Ada2 regulated the histone acetyltransferase activity of Gcn5 and interacts 
with phospholipids. J. Mol. Biol. 384(4):743-55. !
!89
Hoke, S. M., Guzzo, J., Andrews, B., and Brandl, C. J. 2008b. Systematic genetic array  
analysis links the Saccharomyces cerevisiae SAGA/SLIK and NuA4 component Tra1 
to multiple cellular processes. BMC Genet. 9:46. !
Hoke, S. M., Mutiu A, I., Genereaux, J., Kvas, S., Buck, M., Yu, M., Gloor, G. B., and 
Brandl C. J. 2010. Mutational analysis of the C-terminal FATC domain of 
Saccharomyces cerevisiae Tra1. Curr Genet. 56(5):447-65. !
Horejsi, Z., Takai, H., Adelman, C. A., Collis, S. J., Flynn, H., Maslen, S., Skehel, J. M., de 
Lange, T., and Boulton, S. J. 2010. CK2 phospho-dependent binding of R2TP 
complex to TEL2 is essential for mTOR and SMG1 stability. Mol Cell. 39(6):839-50. !
Horiuchi, J., Silverman, N., Pina, B., Marcus, G. A., and Guarente, L. 1997. ADA1, a novel 
component of the ADA/GCN5 complex, has broader effects than GCN5, ADA2, or 
ADA3. Mol Cell Biol. 17(6):3220-28. !
Huh, W.-K., Falvo, J. V., Gerke, L. C., Carroll, A. S., Howson, R. W., Weissman, J. S., and 
O’Shea, E. K. 2003. Global analysis of protein localization in budding yeast. Nature. 
425(6959):686-91. !
Huisinga, K. L., and Pugh, B. F. 2004. A genome-wide housekeeping role for TFIID and a 
highly  regulated stress-related role for SAGA in Saccharomyces cerevisiae. Mol. 
Cell. 13(4):573-85. !
Hurov, K. E., Cotta-Ramusino, C., and Elledge, S. J. 2010. A genetic screen identifies the 
Triple T complex required for DNA damage signalling and ATM and ATR stability. 
Genes Dev. 24(17):1939-50. !
Knuston, B. A., and Hahn, S. 2011. Domains of Tra1 important for activator recruitment 
and transcription coactivator functions of SAGA and NuA4 complexes. Mol Cell 
Biol. 31(4):818-31. !
Krebs, J. E. 2007. Moving marks: dynamic histone modifications in yeast. Mol Biosyst. 
3(9):590-7. !
Krick, R., Tolstrup, J., Appelles, A., Henke, S., and Thumm, M. 2006. The relevance of the 
phosphatidylinositolphosphat-binding motif FRRGT of Atg18 and Atg21 for the Cvt 
pathway and autophagy. FEBS Lett. 580(19):4632-8. !
Kronberg, R. D. 2001. The eukaryotic gene transcription machinery. Biol Chem. 382(8):
1103-7. !
!90
Kuo, M. H., Brownell, J. E., Sobel, R. E., Ranalli, T. A., Cook, R. G., Edmondson, D. G., 
Roth, S. Y., and Allis, C. D. 1996. Transcription-linked acetylation by Gcn5p of 
histones H3 and H4 at specific lysines. Nature. 383(6597):269-72. !
Kvas, S. 2012. Exploring the FATC domain function in yeast tra1 (Master’s thesis). The 
University of Western Ontario, London, ON. !
Lee, K. K., Florens, L., Swanson, S. K., Washburn, M. P., and Workman, J. L. 2005. The  
deubiquitylation  activity of Ubp8 is dependent upon Sgf11 and its association with 
the SAGA complex. Mol Cell Biol. 25:1173-82.  !
Lee, K. K., Sardiu, M. E., Swanson, S. K., Gilmore, J. M., Torok, M., Grant, P. A., Florens, 
L., Workman, J. L., and Washburn, M. P. 2011. Combinatorial depletion analysis to 
assemble the network architecture of the SAGA and ADA chromatin remodeling 
complexes. Mol Syst Biol. 7:503. !
Lempiäinen, H., and Halazonetis, T. D. 2009. Emerging common themes in regulation of 
PIKKs  and PI3Ks. EMBO J. 28(20):3067-73. !
Liu, X., Vorontchikhina, M., Wang, Y. L., Faiola, F., and Martinez, E. 2008. STAGA 
recruits mediator to the MYC oncoprotein to stimulate transcription and cell 
proliferation. Mol Cell Biol. 28(1):109-21. !
Lo, WS., Gamache, E. R., Henry, K, W., Yang, D., Pillus, L., and Berger, S. L. 2005. 
Histone H3 phosphorylation can promote TBP recruitment through distinct promoter-
specific mechanisms. EMBO. 24:997-1008. !
Marcus, G. A., Horiuchi, J., Silverman, N., and Guarente, L. 1996. ADA5/SPT20 links the 
ADA and SPT genes, which are involved in yeast transcription. Mol Cell Biol. 
16:3197-3205. !
Martelli AM1, Bortul R, Tabellini G, Aluigi M, Peruzzi D, Bareggi R, Narducci P, Cocco L. 
2001. Re-examination of the mechanisms regulating nuclear inositol lipid 
metabolism. FEBS Lett. 505:1-6. !
McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., and Cole, M. D. 1998. 
The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and 
E2F oncoproteins. Cell. 94:363-74. !
Mischerikow, N., Spedale, G., Altelaar, A. F., Timmers, H. T., Pijnappel, W. W., and Heck, 
A. J. 2009. In-depth profiling of post-translational modifications on the related 
transcription factor complexes TFIID and SAGA. J Proteome Res. 8(11):5020-30. !
!91
Miller, G. J., Dunn, S. D., and Ball, E. H. 2001. Interaction of the N- and C-terminal 
domains of vinculin. Characterization and mapping studies. J Biol Chem. 276(15):
11729-34. !
Mohibullah, N., and Hahn, S. 2008. Site-specific cross-linking of TBP in vivo and in vitro 
reveals a direct functional interaction with the SAGA subunit Spt3. Genes Dev. 
22(21):2994-3006. !
Muhlemann, O., Eberle, A. B., Stalder, L., and Zamudio Orozco, R. 2008. Recognition and 
elimination of nonsense mRNA. Biochim Biophys Acta. 1779:538-49. !
Mutiu, A. L., Hoke, S. M. T., Genereaux, J., Hannam, C., MacKenzie, K., Jobin-Robitaille, 
O., Guzzo, J., Cote, J., Andrews, B., Haniford, D. B., and Brandl, C. J. 2007. 
Structure/ function analysis of the phosphatidylinositol-3-kinase domain of yeast 
tra1. Genetics. 177(1):151-66. !
Nakada, D., Hirano, Y., Tanaka, Y., and Sugimoto, K. 2005. Role of the C terminus of Mec1 
checkpoint kinase in its localization to sites of DNA damage. Mol Biol Cell. 
16:5227-35. !
Van Oevelen, C. J. C., Teeffelen, Hetty A. A. M., Werven, F. J., and Timmers, H. T. 2005. 
Snf1p-dependent Spt7-Ada-Gcn5-acetyltransferase (SAGA) recruitment and 
chromatin remodeling activities on the HXt2 and HXT4 promoters. J. Biol. Chem. 
281(7):4523-31. !
Park, J., Kunjibettu, S., McMahon, S. B., and Cole., M. D. 2001. The ATM-related domain 
of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent 
oncogenesis. Genes Dev. 15:1619-24. !
Perera, N. M., Michell, R. H., and Dove, S. K. 2004. Hypo-osmotic stress activates Plc1p-
dependent phospatidylinositol 4,5-bisphosphate hydrolysis and inositol 
hexakisphosphate accumulation in yeast. J Biol Chem. 279:5216-26. !
Pray-Grant M. G., Schieltz, D., McMahon, S. J., Wood, J. M., Kennedy, E.L., Cook, R. G., 
Workman, J. L., Yates, J. R., and Grant, P. A. 2002. Novel SLIK histone 
acetyltransferase complex functions in the yeast retrograde response pathway. Mol 
Cell Biol. 22:8774-86. !
Qiu, H., Hu, C., Zhang, F., Hwang, G. J., Swanson, M. J., Boonchird, C., and Hinnebusch, 
A. G. 2005. Interdependent recruitment of SAGA and Srb mediator by transcriptional 
activator Gcn4p. Mol Cell Biol. 25:3461-74. !
!92
Rando, O. J., and Winston, F. 2012. Chromatin and transcription in yeast. Genetics. 190: 
351-387. !
Reeves W. M., and Hahn S. 2005. Targets of the Gal4 transcription activator in functional 
transcription complexes. Mol Cell Biol. 25:9092-9102. !
Rivera-Calzada, A., Maman, J. D., Spagnolo, L., Pearl, L. H., and Llorca, O. 2005. Three-
dimensional structure and regulation of the DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs). Structure. 13(2):243-55. !
Rodriguez-Navarro, S. Fischer, T., Luo, M. J., Antunez, O., Brettschneider, S., Lechner, J., 
Perez-Ortin, J. E., Reed, R., and Hurt, E. 2004. Sus1, a functional component of the 
SAGA histone acetylase complex and the nuclear pore-associated mRNA export 
machinery. Cell. 116(1):75-86. !
Rosenhouse-Dantsker, A., and Logothetis, D. E. 2007. Molecular characteristics of 
phosphoinositide binding. Eur J Physiol. 455:45-53. !
Ruiz-Garcia, A. B., Sendra, R., Pamblanco, M., and Tordera, V. 1997. Gcn5p is involved in 
the acetylation of histone H3 in nucleosomes. FEBS Lett. 403:186-90. !
Saleh, A., Lang, V., Cook, R., Brandl, C. J. 1997. Identification of native complexes 
containing the yeast coactivator/repressor proteins Ngg1/Ada3 and Ada2. J Biol 
Chem. 272(9):5571-8.  !
Saleh, A., Schieltz, D., Ting, N., McMahon, S. B., Litchfield, D. W., Yates, J. R., Lees-
Miller, S. P., Cole, M. D., and Brandl, C. J. 1999. Tra1p is a component of the yeast 
Ada-Spt trancriptional regulatory complexes. J Biol Chem. 273(41):26559-65. !
Schink, K. O., Raiborg, C., and Stenmark, H. Phosphatidylinositol 3-phosphate, a lipid that 
regulates membrane dynamics, protein sorting and cell signalling. Bioessays. 35(10):
900-12. !
Schu, P. V., Takegawa, K., Fry, M. H., Stack, J. H., Waterfield, M. D., and Emr, S. D. 1993. 
Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein 
sorting. Science. 260(5104):88-91. !
Shevchenko, A., Roguev, A., Schaft D., Buchanan, L., Habermann, B., Sakalar, C., Thomas, 
H., Krogan, N. J., Shevchenko, A., and Stewart, A. F. 2008. Chromatin Central: 
towards the comparative proteome by accurate mapping of the yeast proteomic 
environment. Genome Biol. 9:R167. !
!93
Shisheva, A. 2013. PtdIns5P: news and views of its appearance, disappearance and deeds. 
Arch Biochem Biophys. 538(2):171-80. !
Shukla, A., Stanojevic, N., Duan, Z., Sen, P., and Bhaumik, S. R. 2006. Ubp8p, a histone 
deubiquitinase whose association with SAGA is mediated by Sgf11p, differentially  
regulates lysine 4 methylation of histone H3 in vivo. Mol and Cell Biol. 26(9):
3339-52. !
Steglich, B., Sazer, S., and Ekwall, K. 2013. Transcriptional regulation at the yeast nuclear 
envelope. Nucleus. 4(5):379-89.  !
Sterner, D. E., and Berger, S. L. 2000. Acetylation of histones and transcription-related 
factors. Microbiol Mol Biol Rev. 64(2):435-59. !
Sterner, D. E., Grant, P. A., Roberts, S. M., Duggan, L. J., Belotserkovskava, R., Pacella, L. 
A., Winston, F., Workman, J. L., and Berger, S. L. 1999. Functional organization of 
the yeast SAGA complex: distinct components involved in structural integrity, 
nucleosome acetylation, and TATA-binding protein interaction. Mol Cell Biol. 19(1):
86-98. !
Sterner, D. E., Belotesrkovskaya, R., and Berger, S. L. 2002. SALSA, a variant of yeast 
SAGA, contains truncated Spt7, which correlates with activated transcription. Proc 
Natl Acad Sci. 99(18):11622-27. !
Strahl, T., Hama, H., DeWald, D. B., and Thorner, J. 2005. Yeast phosphatidylinositol 4-
kinase, Pik1, has essential roles at the Golgi and in the nucleus. J Cell Biol. 171(6):
967-79.  !
Strahl, T., and Thorner, J. 2007. Synthesis and function of membrane phosphoinositides in 
budding yeast Saccharomyces cerevisiae. Biochim Biophys Acta. 1771(3):353-404. !
Sturgill, T. W., and Hall, M. N. 2009. Activating mutations in TOR are in similar structures 
as oncogenic mutations in PI3KCalpha. ACS Chem Biol. 4(12):999-1015.  !
Syntichaki, P., Topalidou, I., and Thireos, G. 2000. The Gcn5 bromodomain co-ordinates 
nucleosome remodelling. Nature. 404:414-17. !
Takahashi, T., Hara, K., Inoue, H., Kawa, Y., Tokunaga, C., Hidayat, S., Yoshino, K., 
Kuroda, Y., and Yonezawa, K. 2000. Carboxy-terminal region conserved among 
phosphoinositide-kinase-related kinases is indispensable for mTOR function in vivo 
and in vitro. Genes Cells. 5(9):765-75. !
!94
Takai, H., Wang, R. C., Takai, K. K., Yang, H., and de Lange, T. 2007. Tel2 regulates the 
stability of PI3K-related protein kinases. Cell. 131(7):1248-59. !
Thomas, M. C., and Chiang, C-M. 2006. The general transcription machinery and general 
cofactors. Critical Rev in Biochem and Mol Biol. 41(3):105-78. !
Warfield L., Ranish, J. A., and Hahn, S. 2004. Positive and negative functions of the SAGA 
complex mediated through interaction of Spt8 with TBP and the N-terminal domain 
of TFIIA. Genes Dev. 18(9):1022-43. !
Winston, F., and Allis, C. D. 1999. The bromodomain: a chromatin-targeting module? Nat 
Struct Biol: 6(7):601-4. !
Winston, F., and Carlson, M. 1992. Yeast SNF/SWI transcriptional activators and the SPT/
SIN chromatin connection. Trends Genet. 8(11):387-91. !
Wu, P. Y., Ruhlmann, C., Winston, F., and Schultz, P. 2004. Molecular architecture of the S. 
cerevisiae SAGA complex. Mol Cell. 15(2):199-208. !
Wu, P. Y., and Winston, F. 2002. Analysis of Spt7 function in the Saccharomyces cerevisiae 
SAGA coactivator complex. Mol Cell Biol. 22(15):5367-79. !
Yang, H., Rudge, D. G., Koos, J. D., Vaidialingam, B., Yang, H. J., and Pavletich, N. P. 
2013. mTOR kinase structure, mechanism and regulation. Nature. 497(7448):217-23. !
Yu, Y., Eriksson, P., Bhoite, L. T., and Stillman, D. J. 2003. Regulation of TATA-binding 
protein binding by the SAGA complex and the Nhp6 high-mobility group protein. 
Mol Cell Biol. 23(6):1910-21. !
Yu, J. W., Mendrola, J. M., Audhya, A., Singh, S., Keleti, D., DeWald, D. B., Murray, D., 
Emr, S. D., and Lemmon, M. A. 2004. Genome-wide analysis of membrane targeting 
by S. cerevisiae pleckstrin homolgy domains. Mol Cell. 13(5):677-88. !
Zhang, Y., and Reinberg, D. 2001. Transcription regulation by histone methylation: 
interplay between covalent modifications of the core histone tails. Genes Dev. 15(18):
2343-60. !
!
!
!
Appendix
Table S1: Saccharomyces cerevisiae strains used in this study
Strain Description Plasmids References
KY320 MATa ura3-52 ade2-101 trp1-Δ1 lys2-801 his3-
Δ200 leu2::PET56
- Chen, 1988
FY630 MATa ura3–52 ade8 trp-Δ63 his917 Δlys2– 
801173R2 leu2Δ1
- Gansheroff et 
al. 1995
FY1093 MATa spt7-402::LEU2 his4-917- lys2-173R2 leu2-1 
ura3-52 trp1-63 ade8 
- Gansheroff et 
al. 1995
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 - Winzeler and 
Davis, 1997
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 - Winzeler and 
Davis, 1997
CY4359 isogenic to FY1093 CB2154 this study (JG)
CY4367 isogenic to FY1093 CB2157 this study (JG)
CY4384 isogenic to FY1093 CB2162 this study (JG)
CY4385 isogenic to FY1093 CB2161 this study (JG)
CY4465 MATa spt7-402::URA3 his4-917- lys2-173R2 leu2-1 
ura3-52 trp1-63 ade8
- this study (JG)
CY5616 isogenic to FY1093 CB2216 this study (JG)
CY5795 isogenic to CY4465 DD20 this study (JG)
CY5796 isogenic to CY4465 CB2157 this study (JG)
CY5797 isogenic to CY4465 CB2273 this study (JG)
CY5798 isogenic to CY4465 DD19 this study (JG)
CY5921 isogenic to BY4741 DD28 this study (DD)
CY5922 isogenic to BY4741 DD29 this study (DD)
CY5854 isogenic to BY4741 CB2282 this study (DD)
CY6025 MATα ura3D0 his3D0 leu2D0 URA3-eGFP-tra1-
F3744A-HIS3 x BY4741
- Genereaux et 
al. 2012
CY6029 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 URA3-eGFP-
TRA1 x BY4741
- Genereaux et 
al. 2012
CY6062 isogenic to BY4741 CB2322 Genereaux et 
al. 2012
CY6063 MATα ura3D0 his3D0 leu2D0 tti2-F328S URA3-
eGFP-tra1-F3744A-HIS3 x BY4741
CY1932 Genereaux et 
al. 2012
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CY6079 isogenic to BY4741 CB1966 this study (DD)
CY6085 isogenic to BY4742 except spt7-402::LEU2 and 
fab1Δ::KanMX4
CB1966 this study (DD)
CY6086 isogenic to BY4742 except spt7-402::LEU2 and 
fab1Δ::KanMX4
DD28 this study (DD)
CY6087 isogenic to BY4742 except spt7-402::LEU2 and 
fab1Δ::KanMX4
DD29 this study (DD)
CY6089 isogenic to CY6085 except vps34Δ::KanMX4 CB1966 this study (DD)
CY6090 isogenic to CY6086 except vps34Δ::KanMX4 DD28 this study (DD)
CY6091 isogenic to CY6087 except vps34Δ::KanMX4 DD29 this study (DD)
CY6099 isogenic to FY1093 DD31 & DD33 this study (DD)
CY6108 MATa spt7-402::TRP1 his4-917- lys2-173R2 leu2-1 
ura3-52 trp1-63 ade8
CB2288 this study (JG)
CY6110 MATa spt7-402::TRP1 his4-917- lys2-173R2 leu2-1 
ura3-52 trp1-63 ade8
CB2293 this study (JG)
CY6139 isogenic to CY5871 CB1779 & CB2293 this study (DD)
CY6161 isogenic to BY4742 DD37 this study (DD)
CY6162 isogenic to BY4742 DD38 this study (DD)
CY6308 isogenic to FY630 DD33 & DD39 this study (DD)
*All strains referenced as from “this study” were generated by the author of this thesis, Dominik 
Dobransky (DD), or Julie Genereaux (JG) as indicated. All strains indicated as from Genereaux et 
al (2012) were engineered by Dr. Brandl.
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Table S2: DNA constructs used in this study
Name Description
DD6 1-73 residue fragment of Spt7 in pGEX-KGT expression vector (Miller et al. 2001) 
DD7 1-73 R4QK8QR12QK16Q fragment of Spt7 in GEX-KGT expression vector 
DD13 1-73-R4QK8Q mutant fragment of Spt7 in pGEX-KGT expression vector 
DD14 1-73-R12QK16Q mutant fragment of Spt7 in GEX-KGT expression vector
DD18 intermediate molecule containing 1441 bp piece from CB2157 cloned into DD14 HindIII/
HindIII
DD19 Full length Spt7 carrying R4QK8Q mutation in YCplac22 (N-terminal myc9 trp+ cen DED1 
promoter)
DD20 Full length Spt7 carrying R12QK16Q mutation in YCplac22 (N-terminal myc9 trp+ cen DED1 
promoter)
DD21 eGFP-Spt7 carrying R12QK16Q mutation in pEGFP-C3 (Clontech Laboratories, Inc; Hoke et 
al. 2008b)
DD22 eGFP-Spt7 carrying R4QK8Q mutation in pEGFP-C3 (Clontech Laboratories, Inc; Hoke et al.  
2008b)
DD27 eGFP-Spt7 carrying R4QK8QR12QK16Q mutation in pEGFP-C3 (Clontech Laboratories, Inc; 
Hoke et al. 2008b)
DD28 eGFP-Spt7 carrying 121-1332 truncation in pEGFP-C3 (Clontech Laboratories, Inc; Hoke et 
al. 2008b)
DD29 eGFP-Spt7 carrying 73-1332 truncation in pEGFP-C3 (Clontech Laboratories, Inc; Hoke et 
al. 2008b)
DD31 Spt7WT in YCplac22 (N-terminal flag3 TRP CEN DED1 promoter)
DD32 Spt71-121Δ in YCplac22 (N-terminal flag3 TRP CEN DED1 promoter)
DD33 Gcn5WT in YEplac195 (N-terminal myc9 URA 2µ DED1 promoter) 
DD36 N-terminal 1-120 residue fragment of Spt7 in YCplac22 N-terminal flag3 TRP cen DED1 
promoter
DD37 N-terminal 1-120 residue fragment of Spt7 in YEplac195 (N-terminal myc9 URA 2µ DED1 
promoter)
DD38 eGFP-tagged 1-120 residue fragment of Spt7 in pEGFP-C3 (Clontech Laboratories, Inc; Hoke 
et al. 2008b)
DD39 Spt7121-1332 YEplac112 (TRP 2µ flag3)
CB1779 wild-type Tra1 in YCplac22 (N-terminal flag3 TRP cen DED1 promoter)
CB2157 Spt7WT in YCplac22 (N-terminal myc9 TRP cen DED1 promoter)
CB2161 Spt7121-1332 in YCplac112 (N-terminal myc9 TRP 2µ DED1 promoter)
CB2216 Spt773-1332 in YCplac112 (N-terminal myc9 TRP 2µ DED1 promoter)
CB2288 Spt7WT in YEplac195 (N-terminal myc9 URA 2µ DED1 promoter)
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CB2293 Spt7121-1332 in YEplac195 (N-terminal myc9 URA 2µ DED1 promoter)
CB1503 LacZ-PHO5 fusion in LEU2 centromeric plasmid YCp87 (Brandl et al. 1993)
CB1467 LacZ-INO1 fusion in LEU2 centromeric plasmid YCp87 (Brandl et al. 1993)
CB2112 LacZ-SRE/His3 fusion in LEU2 centromeric plasmid YCp87 (Hoke et al. 2010)
CB1533 LacZ-Rpl35A fusion in LEU2 centromeric plasmid YCp87
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Table S3: Oligonucleotides used in this study
Name Sequence (5` to 3`) Description
3203-1 cgggatccttaagaggccaacgtcgatg primer for 5` end of promoter 
region of RPL35A into His4. 
Has a BamHI site in frame for 
LacZ fusion
3203-2 cggaagcttccatttgcaatatactgtctcac primer for 3` end of promoter 
region of RPL35A into His3. 
Has a HindIII site in frame for 
LacZ fusion
5077-1 atgcggatccacaatggtgagcaagggcgagg primer for amplifying eGFP 
from the eGFP-C3 plasmid. 
Contains BamHI site
5077-2 ttttccttttgcggccgccttgtacagctcgtccatg primer for amplifying eGFP 
from the eGFP-C3 plasmid. 
Contains NotI site
5914-1 gatccatgacggaacagattcctattcagaactatcaacagacgaatgcgca primer to kinase, anneal to 
5914-2 and ligate into DD5-
Spt7 construct - first four 
positive residues changed to 
Gln
5914-2 agcttgcgcattcgtctgttgatagttctgaataggaatctgttccgtcatg primer to kinase, anneal to 
5914-1 and ligate into DD5-
Spt7 construct - first four 
positive residues changed to 
Gln
5939-1 agggatccatgactgaacagataccaatacagaattatcaaagaac N-term Spt7 mutant (R4QK8Q) 
to amplify off of the wild type 
strand (1-73 wild-type Spt7 in 
Y240 vector with filled in 
HindIII; DNA DD6)
5939-2 agggatccatgacggaaagaattcctattaagaactatcaacagac N-term Spt7 mutant 
(R12QK16Q) to amplify off of 
the DD7 mutant strand (1-73 
R4QK8QR12QK16Q Spt7 in 
Y240 vector with filled in 
HindIII
5799-1 ggaattctatttttcgacatttaatgctatgtt primer to clone piece of Spt7 
into y61 as GST fusion. Non-
coding strand, stops at residue 
73 (has engineered stop codon).
6001-1 ataagaatgcggccgccatgactgaacagataccaa Forward primer with NotI site 
to PCR up DD17 (intermediate 
molecule carrying R4K8 
mutation of Spt7 N-term), to 
clone mutation into full length 
Spt7 for yeast studies
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6001-2 ataagaatgcggccgccatgacggaaagaattcc Forward primer with NotI site 
to PCR up DD18 (intermediate 
molecule carrying R12K16 
mutation of Spt7 N-term), to 
clone mutation into full length 
Spt7 for yeast studies
5741-1 ataagaatgcggccgctgttgaaaatgaaattgaagataaag primer to clone piece of Spt7 
into N-terminal 9-myc plasmid 
with NotI at 5` end
5741-2 cagtattcaggtccatggact 3’ primer in Spt7 at base pair 
1471. Non-coding strand, 
includes native NcoI site.
4051-1 gcggccgcaatgactgaaagaataccaataaag 5' primer of Spt7 gene
5705-1 ggaattctaatgattttcattgctgatactgg primer to clone piece of Spt7 
into y61 as GST fusion. non-
coding strand, stops at residue 
120 (has engineered stop 
codon).
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